Hustinx Roland

Département des sciences cliniques > Médecine nucléaire

GIGA CRC In vivo Imaging - Nuclear Medicine Division

See author's contact details
ORCID
0000-0001-7164-8742
Main Referenced Co-authors
Lovinfosse, Pierre  (56)
Withofs, Nadia  (47)
Jerusalem, Guy  (40)
Bernard, Claire  (36)
Rigo, Pierre  (36)
Main Referenced Keywords
Humans (52); FDG (37); Positron emission tomography (33); PET (31); Oncology (28);
Main Referenced Unit & Research Centers
GIGA CRC (Cyclotron Research Center) In vivo Imaging-Aging & Memory - ULiège [BE] (7)
Centre Régional de Lutte Contre le Cancer (CRLCC) Eugène Marquis, Rennes, France (3)
Département de Médecine Nucléaire, CHU d'Angers, France (3)
Département de Médecine Nucléaire, CHU de Liège, Belgique (3)
INSERM UMR_S 1066 MINT (Micro- et Nanomédecines Biomimétiques), Université d'Angers, France (3)
Main Referenced Disciplines
Radiology, nuclear medicine & imaging (275)
Oncology (82)
Neurology (35)
Surgery (34)
Hematology (24)

Publications (total 412)

The most downloaded
2584 downloads
JODOGNE, S., LENAERTS, E., COUCKE, P., & HUSTINX, R. (2014). Orthanc - Logiciel libre pour l'imagerie médicale en milieu hospitalier. In Communications de la Conférence Francophone en Gestion et Ingénierie des Systèmes Hospitaliers (GISEH 2014). https://hdl.handle.net/2268/170509

The most cited

1215 citations (Scopus®)

BARRINGTON, S. F., MIKKHAEEL, N. G., KOSTAKOGLU, L., MEIGNAN, M., HUTCHINGS, M., MUELLER, S. P., SCHWARTZ, L. H., ZUCCA, E., FISHER, R. I., TROTMAN, J., HOEKSTRA, O. S., HICKS, R. J., O'DOHERTY, M. J., HUSTINX, R., BIGGI, A., & CHESON, B. D. (2014). Role of Imaging in the Staging and Response Assessment of Lymphoma : Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. Journal of Clinical Oncology. doi:10.1200/JCO.2013.53.5229 https://hdl.handle.net/2268/171841

LOUIS, T., Lucia, F., Cousin, F., MIEVIS, C., Jansen, N., Duysinx, B., Le Pennec, R., Visvikis, D., Nebbache, M., Rehn, M., Hamya, M., Geier, M., Salaun, P.-Y., Schick, U., Hatt, M., Coucke, P., Lovinfosse, P., & Hustinx, R. (19 April 2024). Identification of CT radiomic features robust to acquisition and segmentation variations for improved prediction of radiotherapy-treated lung cancer patient recurrence. Scientific Reports, 14 (1), 9028. doi:10.1038/s41598-024-58551-4
Peer Reviewed verified by ORBi

Sakalihasan, N., Brüls, S., Hustinx, R., Tchana-Sato, V., SAKALIHASAN, S., Hultgren, R., Labropoulos, N., Colige, A., Durieux, R., Drion, P., Albert, A., Defraigne, J.-O., & MUSUMECI, L. (09 March 2024). Association between PET/CT Scan Findings, Treatment, and Cancer Incidence in a Cohort of AAA Patients. Journal of Clinical Medicine, 13 (6), 1569. doi:10.3390/jcm13061569
Peer Reviewed verified by ORBi

LUCIA, F., Withofs, N., Lovinfosse, P., & Hustinx, R. (2024). TEP/TDM en radiothérapie : indications et perspectives. Revue Médicale de Liège.
Editorial Reviewed verified by ORBi

Lucia, F., MIEVIS, C., Jansen, N., Duysinx, B., Cousin, F., LOUIS, T., BAIWIR, M., ERNST, C., WONNER, M., Hustinx, R., Lovinfosse, P.* , & Coucke, P.*. (2024). Predictive clinical and dosimetric parameters for risk of relapse in early-stage non-small cell lung cancer treated by SBRT: A large single institution experience. Clinical and Translational Radiation Oncology, 100720. doi:10.1016/j.ctro.2023.100720
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Fank, H.* , Weekers, L.* , Lovinfosse, P.* , Pottel, H., Seidel, L., Jadoul, A., Bouquegneau, A., BONVOISIN, C., Bovy, C., GROSCH, S., Erpicum, P., Hustinx, R., & Jouret, F. (25 August 2023). The uptake of [18F]-fluorodeoxyglucose by the renal allograft correlates with the acute Banff scores of cortex inflammation but not with the 1-year graft outcomes. Frontiers in Transplantation, 2. doi:10.3389/frtra.2023.1236751
Peer reviewed
* These authors have contributed equally to this work.

Lucia, F., Lovinfosse, P., Schick, U., Le Pennec, R., Pradier, O., Salaun, P.-Y., Hustinx, R., & Bourbonne, V. (2023). Radiotherapy modification based on artificial intelligence and radiomics applied to (18F)-fluorodeoxyglucose positron emission tomography/computed tomography. Cancer Radiotherapie. doi:10.1016/j.canrad.2023.06.001
Peer Reviewed verified by ORBi

Vandenberghe, S., Muller, F. M., Withofs, N., Dadgar, M., Maebe, J., Vervenne, B., Akl, M. A., Xue, S., Shi, K., Sportelli, G., Belcari, N., Hustinx, R., Vanhove, C., & Karp, J. S. (2023). Walk-through flat panel total-body PET: a patient-centered design for high throughput imaging at lower cost using DOI-capable high-resolution monolithic detectors. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-023-06341-x
Peer Reviewed verified by ORBi

Rinkin, C., CHAUVEHEID, F., GERARD, C., Seidel, L., Hustinx, R., Ribbens, C., & Malaise, O. (2023). [18F] positron emission computed tomography ([18F] FDG PET/CT) is able to predict ultrasound-defined remission in rheumatoid arthritis. Annals of the Rheumatic Diseases.
Peer Reviewed verified by ORBi

Gear, J., Stokke, C., Terwinghe, C., Gnesin, S., Sandström, M., Tran-Gia, J., Cremonesi, M., Cicone, F., Verburg, F., Hustinx, R., Giovanella, L., Herrmann, K., Gabiña, P. M. (June 2023). EANM enabling guide: how to improve the accessibility of clinical dosimetry. European Journal of Nuclear Medicine and Molecular Imaging, 50 (7), 1861 - 1868. doi:10.1007/s00259-023-06226-z
Peer Reviewed verified by ORBi

Leijenaar, R. T. H., Walsh, S., Akshayaa Vaidyanathan, Aliboni, L., Sanchez, V. L., Leech, M., Joyce, R., Gillham, C., Kridelka, F., Hustinx, R., Danthine, D., Occhipinti, M., Vos, W., Guiot, J., Lambin, P., & Lovinfosse, P. (03 May 2023). External validation of a radiomic signature to predict p16 (HPV) status from standard CT images of anal cancer patients. Scientific Reports, 13 (1), 7198. doi:10.1038/s41598-023-34162-3
Peer Reviewed verified by ORBi

Burniat, A., Noël, A., Colige, A., Vanderplasschen, A., de Kerchove d'Exaerde, A., Kupper Cardozo, A., Van Keymeulen, A., Moens, A., Bondue, A., Herpain, A., Marchant, A., Loumaye, A., Beck, B., Van den Heyden, B., Corvilain, B., Lakaye, B., Rogister, B., Malgrange, B., Michiels, C., ... Brunko, E. (2023). Cent scientifiques répliquent à SEA (Suppression des Expériences sur l’Animal vivant) et dénoncent sa désinformation. La Libre Belgique.

Sanz, L.* , Szymkowicz, E.* , Lejeune, N., Bonin, E., Sala, A., Panda, R., Thibaut, A., Dardenne, N., Dikenstein, D., Van Goethem, S., Ledoux, D., Hustinx, R., Laureys, S., & Gosseries, O. (01 April 2023). Multimodal open-label study of apomorphine in disorders of consciousness [Paper presentation]. 14th Biennial World Congress on Brain Injury, Dublin, Ireland.
Peer reviewed
* These authors have contributed equally to this work.

Cousin, F., Louis, T., Dheur, S., Aboubakar, F., Ghaye, B., Occhipinti, M., Vos, W., Bottari, F., PAULUS, A., Sibille, A., VAILLANT, F., Duysinx, B., Guiot, J., & Hustinx, R. (25 March 2023). Radiomics and Delta-Radiomics Signatures to Predict Response and Survival in Patients with Non-Small-Cell Lung Cancer Treated with Immune Checkpoint Inhibitors. Cancers, 15 (7), 1968. doi:10.3390/cancers15071968
Peer Reviewed verified by ORBi

D'Angelo, L., Parent, A.-S., Derwael, C., Hustinx, R., & Seghaye, M.-C. (17 March 2023). Unusual Cardiac Manifestations of a Pheochromocytoma in a Girl. Pediatric Reports, 15 (1), 237-244. doi:10.3390/pediatric15010019
Peer Reviewed verified by ORBi

Lucia, F., Bourbonne, V., PLEYERS, C., Dupré, P.-F., Miranda, O., Visvikis, D., Pradier, O., Abgral, R., Mervoyer, A., Classe, J.-M., Rousseau, C., Vos, W., HERMESSE, J., Gennigens, C., De Cuypere, M., Kridelka, F., Schick, U., Hatt, M., Hustinx, R., & Lovinfosse, P. (2023). Multicentric development and evaluation of 18F-FDG PET/CT and MRI radiomics models to predict para-aortic lymph node involvement in locally advanced cervical cancer. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-023-06180-w
Peer Reviewed verified by ORBi

LAMBRECHT, C., Vandermeulen, M., DELBOUILLE, M.-H., MONARD, J., WARMOES, A., AMICONE, C., Warling, O., Lamproye, A., Delwaide, J., MEURISSE, N., Honoré, P., Hustinx, R., Lovinfosse, P., & Detry, O. (March 2023). 18FDG PET scanner as a selection criterion in liver transplantation for hepatocarcinoma. Acta Gastro-Enterologica Belgica, 86 (1), 17.
Peer Reviewed verified by ORBi

Lovinfosse, P., Vieujean, S., Louis, E., & Hustinx, R. (2023). Commentary to "[68 Ga]Ga-FAPI-04 PET/CT on assessing Crohn's disease intestinal lesions" by Chen and colleagues. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-023-06135-1
Peer Reviewed verified by ORBi

Ibrahim, A. K., Vaidyanathan, A., Primakov, S., Belmans, F., Bottari, F., Refaee, T., Lovinfosse, P., Jadoul, A., Derwael, C., Hertel, F., Woodruff, H. C., Zacho, H. D., Walsh, S., Vos, W., Occhipinti, M., Hanin, F.-X., Lambin, P., Mottaghy, F. M., & Hustinx, R. (25 January 2023). Deep learning based identification of bone scintigraphies containing metastatic bone disease foci. Cancer Imaging, 23 (1), 12. doi:10.1186/s40644-023-00524-3
Peer reviewed

Lucia, F., LOUIS, T., Cousin, F., Bourbonne, V., Visvikis, D., MIEVIS, C., Jansen, N., Duysinx, B., Le Pennec, R., Nebbache, M., Rehn, M., Hamya, M., Geier, M., Salaun, P.-Y., Schick, U., Hatt, M., Coucke, P., Hustinx, R., & Lovinfosse, P. (2023). Multicentric development and evaluation of [ 18 F]FDG PET/CT and CT radiomic models to predict regional and/or distant recurrence in early-stage non-small cell lung cancer treated by stereotactic body radiation therapy. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-023-06510-y
Peer Reviewed verified by ORBi

Herrmann, K., Giovanella, L., Santos, A., Gear, J., Ozgen Kiratli, P., Kurth, J., Denis-Bacelar, A. M., Hustinx, R., Patt, M., Wahl, R. L., Paez, D., Giammarile, F., Jadvar, H., Pandit-Taskar, N., Ghesani, M., & Kunikowska, J. (December 2022). Joint EANM, SNMMI, and IAEA Enabling Guide: How to Set up a Theranostics Center. Journal of Nuclear Medicine, 63 (12), 1836 - 1843. doi:10.2967/jnumed.122.264321
Peer Reviewed verified by ORBi

Dierckx, R., Herrmann, K., Hustinx, R., Lassmann, M., Wadsak, W., & Kunikowska, J. (December 2022). European Association of Nuclear Medicine (EANM) response to the proposed ASTRO's framework for radiopharmaceutical therapy curriculum development for trainees. European Journal of Nuclear Medicine and Molecular Imaging, 50 (1), 1 - 3. doi:10.1007/s00259-022-06011-4
Peer Reviewed verified by ORBi

Mzaiti, O., Hustinx, R., & Jadoul, A. (December 2022). Idiopathic SIADH: 4 years of diagnostic wandering. European Journal of Nuclear Medicine and Molecular Imaging, 50 (1), 232 - 233. doi:10.1007/s00259-022-05960-0
Peer Reviewed verified by ORBi

Sanz, L.* , Szymkowicz, E.* , Lejeune, N., Bonin, E., Sala, A., Panda, R., Thibaut, A., Dardenne, N., Dikenstein, D., Van Goethem, S., Ledoux, D., Hustinx, R., Laureys, S., & Gosseries, O. (06 September 2022). Apomorphine dopaminergic neuromodulation in severe brain- injured patients with consciousness disorders – a pilot study [Paper presentation]. GIGA day 2022, Liège, Belgium.
* These authors have contributed equally to this work.

Hustinx, R., Pruim, J., Lassmann, M., & Visvikis, D. (2022). An EANM position paper on the application of artificial intelligence in nuclear medicine. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-022-05947-x
Peer Reviewed verified by ORBi

Visvikis, D., Lambin, P., Beuschau Mauridsen, K., Hustinx, R., Lassmann, M., Rischpler, C., Shi, K., & Pruim, J. (2022). Application of artificial intelligence in nuclear medicine and molecular imaging: a review of current status and future perspectives for clinical translation. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-022-05891-w
Peer Reviewed verified by ORBi

WITHOFS, N., Kumar, R., Alavi, A., & HUSTINX, R. (July 2022). Facts and Fictions About [18F]FDG versus Other Tracers in Managing Patients with Brain Tumors: It Is Time to Rectify the Ongoing Misconceptions. PET Clinics, 17 (3), 327-342. doi:10.1016/j.cpet.2022.03.004
Peer Reviewed verified by ORBi

LOVINFOSSE, P., Ferreira, M., WITHOFS, N., JADOUL, A., Derwael, C., Frix, A.-N., GUIOT, J., BERNARD, C., Diep, A. N., Donneau, A.-F., LEJEUNE, M., BONNET, C., Vos, W., Meyer, P., & HUSTINX, R. (19 May 2022). Distinction of lymphoma from sarcoidosis at FDG PET/CT - evaluation of radiomic-feature guided machine learning versus human reader performance. Journal of Nuclear Medicine, 63, 1933-1940. doi:10.2967/jnumed.121.263598
Peer Reviewed verified by ORBi

Denis, C., COUSIN, F., De Laere, B., HUSTINX, R., SAUTOIS, B.* , & WITHOFS, N.*. (21 April 2022). Using, 68Ga-PSMA-11 PET/CT for therapy response assessment in patients with metastatic castration-resistant prostate cancer: an application of EAU/EANM recommendations in clinical practice. Journal of Nuclear Medicine, 63 (12), 1815-1821. doi:10.2967/jnumed.121.263611
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Lamaye, C., Bastin, C., BERNARD, C., WITHOFS, N., HUSTINX, R., & SALMON, E. (April 2022). Analyse comparative de la distribution cérébrale du [18F]FDG dans une population de patients souffrant de maladie d’Alzheimer présentant ou non des antécédents familiaux de démence. Revue Médicale de Liège, 77 (4), 224-230.
Editorial Reviewed verified by ORBi

Refaee, T., Salahuddin, Z., Widaatalla, Y., Primakov, S., Woodruff, H. C., Hustinx, R., Mottaghy, F. M., Ibrahim, A., & Lambin, P. (31 March 2022). CT Reconstruction Kernels and the Effect of Pre- and Post-Processing on the Reproducibility of Handcrafted Radiomic Features. Journal of Personalized Medicine, 12 (4), 553. doi:10.3390/jpm12040553
Peer Reviewed verified by ORBi

Ibrahim, A., Barufaldi, B., Refaee, T., Silva Filho, T. M., Acciavatti, R. J., Salahuddin, Z., Hustinx, R., Mottaghy, F. M., Maidment, A. D. A., & Lambin, P. (22 March 2022). MaasPenn Radiomics Reproducibility Score: A Novel Quantitative Measure for Evaluating the Reproducibility of CT-Based Handcrafted Radiomic Features. Cancers, 14 (7), 1599. doi:10.3390/cancers14071599
Peer Reviewed verified by ORBi

Denis, C., Cousin, F., De Laere, B., Hustinx, R., Sautois, B., & Withofs, N. (2022). Using 68Ga-PSMA-11 PET/CT for therapy response assessment in patients with metastatic castration-resistant prostate cancer : an application of EAU/EANM recommendations in clinical practice [Poster presentation]. BMUC, Belgium.
Editorial reviewed

Sanz, L.* , Szymkowicz, E.* , Lejeune, N., Bonin, E., Sala, A., Panda, R., Thibaut, A., Dardenne, N., Dikenstein, D., Van Goethem, S., LEDOUX, D., HUSTINX, R., LAUREYS, S., & Gosseries, O. (2022). Investigation of apomorphine-related neural mechanisms in severe brain-injured patients with prolonged disorders of consciousness [Paper presentation]. 25th annual meeting of the ASSC, Amsterdam, Netherlands.
Editorial reviewed
* These authors have contributed equally to this work.

Guiot, J.* , Vaidyanathan, A.* , DEPREZ, L., Zerka, F., Danthine, D., Frix, A.-N., Lambin, P., Bottari, F., Tsoutzidis, N., Miraglio, B., Walsh, S., Vos, W., Hustinx, R., Ferreira, M., LOVINFOSSE, P.* , & Leijenaar, R. T. H.*. (2022). A review in radiomics: Making personalized medicine a reality via routine imaging. Medicinal Research Reviews. doi:10.1002/med.21846
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Kirienko, M., Telo, S., HUSTINX, R., Bomanji, J. B., Chiti, A., & Fanti, S. (January 2022). The Impact of COVID-19 on Nuclear Medicine in Europe. Seminars in Nuclear Medicine, 52 (1), 17-24. doi:10.1053/j.semnuclmed.2021.06.022
Peer Reviewed verified by ORBi

Ibrahim, A., Widaatalla, Y., Refaee, T., Primakov, S., Miclea, R. L., Öcal, O., Fabritius, M. P., Ingrisch, M., Ricke, J., HUSTINX, R., Mottaghy, F. M., Woodruff, H. C., Seidensticker, M., & Lambin, P. (16 September 2021). Reproducibility of CT-Based Hepatocellular Carcinoma Radiomic Features across Different Contrast Imaging Phases: A Proof of Concept on SORAMIC Trial Data. Cancers, 13 (18), 4638. doi:10.3390/cancers13184638
Peer Reviewed verified by ORBi

Herrmann, K., Kratochwil, C., Fendler, W. P., Eiber, M., & Hustinx, R. (August 2021). 2021: the year [177Lu]Lu-PSMA-617 RLT PSMA is ready for incorporation into clinical guidelines? : Reply to "A perspective on the EANM procedure guidelines for radionuclide therapy with 177Lu-labelled PSMA-ligands" by Dr. Germo Gericke. European Journal of Nuclear Medicine and Molecular Imaging, 48 (9), 2668 - 2669. doi:10.1007/s00259-021-05409-w
Peer Reviewed verified by ORBi

Mirzaei, S., Prior, J. O., Farsad, M., Lipp, R. W., & Hustinx, R. (August 2021). Ausbildung in Nuklearmedizin und Zukunftsperspektiven. Nuklearmedizin, 60 (4), 264 - 265. doi:10.1055/a-1486-5876
Peer reviewed

Frix, A.-N., COUSIN, F., Refaee, T., Bottari, F., Vaidyanathan, A., DESIR, C., Vos, W., Walsh, S., Occhipinti, M., LOVINFOSSE, P., Leijenaar, R. T. H., HUSTINX, R., MEUNIER, P., LOUIS, R., Lambin, P., & GUIOT, J. (25 June 2021). Radiomics in Lung Diseases Imaging: State-of-the-Art for Clinicians. Journal of Personalized Medicine, 11 (7), 602. doi:10.3390/jpm11070602
Peer Reviewed verified by ORBi

Ibrahim, A., Refaee, T., Primakov, S., Barufaldi, B., Acciavatti, R. J., Granzier, R. W. Y., HUSTINX, R., Mottaghy, F. M., Woodruff, H. C., Wildberger, J. E., Lambin, P., & Maidment, A. D. A. (21 June 2021). Reply to Orlhac, F.; Buvat, I. Comment on "Ibrahim et al. The Effects of In-Plane Spatial Resolution on CT-Based Radiomic Features' Stability with and without ComBat Harmonization. Cancers 2021, 13, 1848". Cancers, 13 (12), 3080. doi:10.3390/cancers13123080
Peer Reviewed verified by ORBi

Ibrahim, A., Refaee, T., Leijenaar, R. T. H., Primakov, S., HUSTINX, R., Mottaghy, F. M., Woodruff, H. C., Maidment, A. D. A., & Lambin, P. (07 May 2021). The application of a workflow integrating the variable reproducibility and harmonizability of radiomic features on a phantom dataset. PLoS ONE, 16 (5), 0251147. doi:10.1371/journal.pone.0251147
Peer Reviewed verified by ORBi

Cousin, F., VALKENBORGH, C., & Hustinx, R. (May 2021). Concepts d’imagerie médicale dans la mise au point et le suivi des cancers : regard sur l’imagerie oncologique. Revue Médicale de Liège, 76 (5-6), 344-351.
Editorial Reviewed verified by ORBi

Konijnenberg, M., Herrmann, K., Kobe, C., Verburg, F., Hindorf, C., Hustinx, R., & Lassmann, M. (2021). EANM position paper on article 56 of the Council Directive 2013/59/Euratom (basic safety standards) for nuclear medicine therapy. European Journal of Nuclear Medicine and Molecular Imaging, 48 (1), 67-72. doi:10.1007/s00259-020-05038-9
Peer Reviewed verified by ORBi

Ibrahim, A., Primakov, S., Beuque, M., Woodruff, H. C., Halilaj, I., Wu, G., Refaee, T., Granzier, R., Widaatalla, Y., Hustinx, R., Mottaghy, F. M., & Lambin, P. (2021). Radiomics for precision medicine: Current challenges, future prospects, and the proposal of a new framework. Methods. doi:10.1016/j.ymeth.2020.05.022
Peer reviewed

LOVINFOSSE, P., Hustinx, R., & Couturier, O.-F. (2021). TEP/TDM multi-phase: revue de la littérature. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique. doi:10.1016/j.mednuc.2021.02.002
Peer Reviewed verified by ORBi

Iantsen, A., Da Silva Ferreira, M., Lucia, F., Jaouen, V., Reinhold, C., Bonaffini, P., Alfieri, J., Rovira, R., Masson, I., Robin, P., Mervoyer, A., Rousseau, C., Kridelka, F., DE CUYPERE, M., LOVINFOSSE, P., Pradier, O., Hustinx, R., Schick, U., Visvikis, D., & Hatt, M. (2021). Convolutional neural networks for PET functional volume fully automatic segmentation: development and validation in a multi-center setting. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05244-z
Peer Reviewed verified by ORBi

Bastin, C., Bahri, M. A., BERNARD, C., HUSTINX, R., & Salmon, E. (2021). Frontal hypometabolism in neurocognitive disorder with behavioral disturbance. Journal of Nuclear Medicine, 62, 1783-1788.
Peer reviewed

Aerts, A., Eberlein, U., Holm, S., Hustinx, R., Konijnenberg, M., Strigari, L., van Leeuwen, F. W. B., Glatting, G., & Lassmann, M. (2021). EANM position paper on the role of radiobiology in nuclear medicine. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05345-9
Peer Reviewed verified by ORBi

Da Silva Ferreira, M., LOVINFOSSE, P., HERMESSE, J., DE CUYPERE, M., Rousseau, C., Lucia, F., Schick, U., Reinhold, C., Robin, P., Hatt, M., Visvikis, D., Bernard, C., Leijenaar, R. T. H., Kridelka, F., Lambin, P., Meyer, P., & Hustinx, R. (2021). [(18)F]FDG PET radiomics to predict disease-free survival in cervical cancer: a multi-scanner/center study with external validation. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05303-5
Peer Reviewed verified by ORBi

Ibrahim, A., Refaee, T., Primakov, S., Barufaldi, B., Acciavatti, R. J., Granzier, R. W. Y., Hustinx, R., Mottaghy, F. M., Woodruff, H. C., Wildberger, J. E., Lambin, P., & Maidment, A. D. A. (2021). The Effects of In-Plane Spatial Resolution on CT-Based Radiomic Features' Stability with and without ComBat Harmonization. Cancers, 13 (8). doi:10.3390/cancers13081848
Peer Reviewed verified by ORBi

COUSIN, F., DESIR, C., BEN MUSTAPHA, S., MIEVIS, C., Coucke, P., & Hustinx, R. (2021). Incidence, risk factors, and CT characteristics of radiation recall pneumonitis induced by immune checkpoint inhibitor in lung cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 157, 47-55. doi:10.1016/j.radonc.2021.01.001
Peer reviewed

Matassa, G., Gelardi, F., Hustinx, R., & Chiti, A. (2021). Highlights of 33rd EANM Annual Congress 2020, virtual edition. European Journal of Nuclear Medicine and Molecular Imaging, 1-5. doi:10.1007/s00259-021-05366-4
Peer Reviewed verified by ORBi

Slart, R. H. J. A., Williams, M. C., Juarez-Orozco, L. E., Rischpler, C., Dweck, M. R., Glaudemans, A. W. J. M., Gimelli, A., Georgoulias, P., Gheysens, O., Gaemperli, O., Habib, G., Hustinx, R., Cosyns, B., Verberne, H. J., Hyafil, F., Erba, P. A., Lubberink, M., Slomka, P., Išgum, I., ... Saraste, A. (2021). Position paper of the EACVI and EANM on artificial intelligence applications in multimodality cardiovascular imaging using SPECT/CT, PET/CT, and cardiac CT. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05341-z
Peer Reviewed verified by ORBi

Neuville, M.* , LOVINFOSSE, P.* , JADOUL, A., THYS, M., SEIDEL, L., Hustinx, R., & Jouret, F. (2021). The use of a visual 4-point scoring scale improves the yield of (18)F-FDG PET-CT imaging in the diagnosis of renal and hepatic cyst infection in patients with autosomal dominant polycystic kidney disease. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-020-04903-x
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

LOVINFOSSE, P., Weekers, F., Pottel, H., BOUQUEGNEAU, A., BONVOISIN, C., BOVY, C., GROSCH, S., Hustinx, R., & Jouret, F. (2021). [(18)F]FDG PET/CT imaging disproves renal allograft acute rejection in kidney transplant recipients with acute kidney dysfunction: a validation cohort. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-021-05467-0
Peer Reviewed verified by ORBi

Rinkin, C., Fosse, P., MALAISE, O., Chapelier, N., Horrion, J., Seidel, L., Albert, A., Hustinx, R., & Malaise, M. (2021). Dissociation between 2-[(18)F]fluoro-2-deoxy-D-glucose positron emission computed tomography, ultrasound and clinical assessments in patients with non-severe rheumatoid arthritis, including remission. BMC Rheumatology, 5 (1), 31. doi:10.1186/s41927-021-00196-1
Peer Reviewed verified by ORBi

GERARD, C., RINKIN, C., Lamaye, C., SEIDEL, L., HUSTINX, R., Malaise, M., & MALAISE, O. (December 2020). Les recommandations « ostéoporose » SFR 2018 identifient une population de polyarthrites rhumatoïdes avec une activité plus élevée et une micro-architecture osseuse (Hr-pQCT) moins bonne : étude de l’influence de la maladie sur les paramètres osseux. Revue du Rhumatisme, 87 (S1), 226. doi:10.1016/j.rhum.2020.10.400
Peer reviewed

Bellier, J., Nokin, M.-J., Caprasse, M., Tiamiou, A., Blomme, A., Scheijen, J. L., KOOPMANSCH, B., MacKay, G. M., Chiavarina, B., Costanza, B., Rademaker, G., Durieux, F., Agirman, F., Maloujahmoum, N., Cusumano, P. G., LOVINFOSSE, P., Leung, H. Y., LAMBERT, F., Bours, V., ... Bellahcene, A. (04 February 2020). Methylglyoxal Scavengers Resensitize KRAS-Mutated Colorectal Tumors to Cetuximab. Cell Reports, 30 (5), 1400-1416.e6. doi:10.1016/j.celrep.2020.01.012
Peer Reviewed verified by ORBi

Derwael, C., Lavergne, O., LOVINFOSSE, P., Nechifor, V., Salvé, M., Waltregny, D., Hustinx, R., & WITHOFS, N. (2020). Interobserver agreement of [(68)Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer. EJNMMI Research, 10 (1), 15. doi:10.1186/s13550-020-0596-4
Peer Reviewed verified by ORBi

DE CUYPERE, M.* , Lovinfosse, P.* , Gennigens, C., HERMESSE, J., Rovira, R., Duch, J., GOFFIN, F., Hustinx, R., & Kridelka, F. (2020). Tumor total lesion glycolysis and number of positive pelvic lymph nodes on pretreatment positron emission tomography/computed tomography (PET/CT) predict survival in patients with locally advanced cervical cancer. International Journal of Gynecological Cancer, 0, 1-8. doi:10.1136/ijgc-2020-001676
Peer reviewed
* These authors have contributed equally to this work.

Meyers, N., JADOUL, A., BERNARD, C., DELWAIDE, J., LAMPROYE, A., DETRY, O., HONORE, P., GERARD, L., & HUSTINX, R. (2020). Inter-observer variability of 90Y PET/CT dosimetry in hepatocellular carcinoma after glass microspheres transarterial radioembolization. EJNMMI Research. doi:10.1186/s40658-020-00302-1
Peer Reviewed verified by ORBi

JADOUL, A., Bernard, C., LOVINFOSSE, P., GERARD, L., LILET, H., Cornet, O., & Hustinx, R. (2020). Comparative dosimetry between (99m)Tc-MAA SPECT/CT and (90)Y PET/CT in primary and metastatic liver tumors. European Journal of Nuclear Medicine and Molecular Imaging, 47 (4), 828-837. doi:10.1007/s00259-019-04465-7
Peer Reviewed verified by ORBi

JADOUL, A.* , LOVINFOSSE, P.* , BOUQUEGNEAU, A., WEEKERS, L., Pottel, H., Hustinx, R., & Jouret, F. (2020). Observer variability in the assessment of renal (18)F-FDG uptake in kidney transplant recipients. Scientific Reports, 10 (1), 4617. doi:10.1038/s41598-020-61032-z
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

CHARLIER, E.* , DEROYER, C.* , NEUVILLE, S., Plener, Z., MALAISE, O., Ciregia, F., Gillet, P., Reuter, G., Salvé, M., Withofs, N., Hustinx, R., de Seny, D., & Malaise, M. (2020). Toward diagnostic relevance of the α(V)β(5), α(V)β(3), and α(V)β(6) integrins in OA: expression within human cartilage and spinal osteophytes. Bone Research, 8, 35. doi:10.1038/s41413-020-00110-4
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Mirzaei, S., Hustinx, R., Prior, J. O., Ozcan, Z., Boubaker, A., Farsad, M., & European Union of Medical Specialists and European Board for Nuclear Medicine. (2020). Improving Nuclear Medicine Practice with UEMS/EBNM Committees. Journal of Nuclear Medicine, 61 (3), 18N-20.
Peer Reviewed verified by ORBi

DE CUYPERE, M., LOVINFOSSE, P., GOFFIN, F., Gennigens, C., Rovira, R., Duch, J., Fastrez, M., Gebhart, G., Squifflet, J. L., Luyckx, M., Charaf, G., Crener, K., Buxant, F., Bucella, D., Jouret, M., Hustinx, R., & Kridelka, F. (2020). Added value of para-aortic surgical staging compared to (18)F-FDG PET/CT on the external beam radiation field for patients with locally advanced cervical cancer: An ONCO-GF study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. doi:10.1016/j.ejso.2019.11.496
Peer reviewed

Da Silva Ferreira, M., LOVINFOSSE, P., DE CUYPERE, M., Rovira, R., Lucia, F., Schick, U., Vallières, M., Bonaffini, P., Reinhold, C., Visvikis, D., Hatt, M., BERNARD, C., Leijenaar, R., Walsh, S., KRIDELKA, F., Meyer, P., & HUSTINX, R. (29 November 2019). FDG PET radiomics to predict disease free survival in Cervical Cancer [Paper presentation]. Bioforum Liege 2019.

Da Silva Ferreira, M., LOVINFOSSE, P., DE CUYPERE, M., Rovira, R. R., Lucia, F., Schick, U., Vallières, M., Bonaffini, P., Reinhold, C., Visvikis, D., Hatt, M., BERNARD, C., Leijenaar, R., Walsh, S., KRIDELKA, F., Meyer, P., & HUSTINX, R. (02 November 2019). FDG PET radiomics to predict disease free survival in Cervical Cancer [Paper presentation]. 2019 IEEE Nuclear Science Symposium & Medical Imaging Conference.

Da Silva Ferreira, M., LOVINFOSSE, P., DE CUYPERE, M., Rovira, R., Lucia, F., Schick, U., Vallières, M., Bonaffini, P., Reinhold, C., Visvikis, D., Hatt, M., BERNARD, C., Leijenaar, R., Walsh, S., KRIDELKA, F., Meyer, P., & HUSTINX, R. (September 2019). Radiomics for Disease Free Survival prediction using pre-treatment FDG PET images [Paper presentation]. "Imaging of diagnostic and therapeutic biomarkers in Oncology“ workshop Manoir de Kerdréan, Le Bono, France, September 25th- 28th, 2019.

Charlier, E., NEUVILLE, S., PLENER, Z., DEROYER, C., RELIC, B., MALAISE, O., REUTER, G., GILLET, P., Salvé, M., WITHOFS, N., HUSTINX, R., DE SENY, D., & MALAISE, M. (May 2019). EXPRESSION OF αVβ5, αVβ3 AND β6 INTEGRINS BY OSTEOARTHRITIC CHONDROCYTES AND VERTEBRAL OSTEOPHYTES [Poster presentation]. OARSI, Toronto, Canada.

Hustinx, R. (2019). Physician centred imaging interpretation is dying out - why should I be a nuclear medicine physician? European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-019-04371-y
Peer Reviewed verified by ORBi

Ibrahim, A., Vallières, M., Woodruff, H., Primakov, S., Beheshti, M., Keek, S., Refaee, T., Sanduleanu, S., Walsh, S., Morin, O., Lambin, P., HUSTINX, R., & Mottaghy, F. M. (2019). Radiomics Analysis for Clinical Decision Support in Nuclear Medicine. Seminars in Nuclear Medicine. doi:10.1053/j.semnuclmed.2019.06.005
Peer Reviewed verified by ORBi

WITHOFS, N., Beguin, Y., COUSIN, F., Tancredi, T., SIMONI, P., Alvarez-Miezentseva, V., DE PRIJCK, B., HAFRAOUI, K., Bonnet, C., Baron, F., Hustinx, R., & Caers, J. (2019). Dual-tracer PET/CT scan after injection of combined [ 18 F]NaF and [ 18 F]FDG outperforms MRI in the detection of myeloma lesions. Hematological Oncology, 37, 193-201. doi:10.1002/hon.2600
Peer Reviewed verified by ORBi

Schielke, A. A., MEURISSE, N., LAMPROYE, A., Honoré, P., Delwaide, J., Hustinx, R., & DETRY, O. (2019). Selection criteria for liver transplantation in patients with hepatocellular carcinoma. Eastern and western experiences, and perspectives for the future. Acta Gastro-Enterologica Belgica, 82 (2), 314-318.
Peer Reviewed verified by ORBi

COURTOIS, A., MAKRYGIANNIS, G., El hachemi, M., Hultgren, R., Allaire, E., Namur, G., HUSTINX, R., DEFRAIGNE, J., & SAKALIHASAN, N. (2019). Positron Emission Tomography/Computed Tomography Predicts and Detects Complications After Endovascular Repair of Abdominal Aortic Aneurysms. Journal of Endovascular Therapy. doi:10.1177/1526602819849088
Peer Reviewed verified by ORBi

Hanssen, O., Weekers, L., Lovinfosse, P., Jadoul, A., Bonvoisin, C., Bouquegneau, A., Grosch, S., Huynen, A., Anglicheau, D., Hustinx, R., & Jouret, F. (2019). Diagnostic yield of (18) F-FDG PET/CT imaging and urinary CXCL9/creatinine levels in kidney allograft subclinical rejection. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. doi:10.1111/ajt.15742
Peer reviewed

Meyer, F., Wehenkel, M., Phillips, C., Geurts, P., HUSTINX, R., Bernard, C., Bastin, C., Salmon, E., & Alzheimer's Disease NeuroImaging Initiative. (2019). Characterization of a temporoparietal junction subtype of Alzheimer’s disease. Human Brain Mapping, 40, 4279-4286. doi:10.1002/hbm.24701
Peer Reviewed verified by ORBi

LOVINFOSSE, P., Hustinx, R., WEEKERS, L., Jouret, F., & DETRY, O. (2019). The role of FDG PET in detecting rejection after liver transplantation [letter to the editor]. Surgery, 165, 853. doi:10.1016/j.surg.2018.06.014
Peer Reviewed verified by ORBi

HANSSEN, O., LOVINFOSSE, P., WEEKERS, L., Hustinx, R., & Jouret, F. (2019). La tomographie par emission de positons au 18F-FDG en pathologie renale non oncologique : indications actuelles et perspectives. Nephrologie & therapeutique. doi:10.1016/j.nephro.2018.11.007
Peer reviewed

LOVINFOSSE, P., HATT, M., VISIKIS, D., & HUSTINX, R. (2018). Heterogeneity analysis of 18F‑FDG PET imaging in oncology: clinical indications and perspectives. Clinical and Translational Imaging. doi:10.1007/s40336-018-0299-2
Peer reviewed

LOVINFOSSE, P., VISVIKIS, D., HUSTINX, R., & HATT, M. (2018). FDG PET radiomics: a review of the methodological aspects. Clinical and Translational Imaging. doi:10.1007/s40336-018-0292-9
Peer reviewed

Cambier, A., LEONARD, P., Losson, B., GIOT, J.-B., BLETARD, N., Meunier, P., Hustinx, R., MEURISSE, N., Delwaide, J., Honoré, P., Hayette, M.-P., & Detry, O. (June 2018). Alveolar echinococcosis in southern Belgium: retrospective experience of a tertiary center. European Journal of Clinical Microbiology and Infectious Diseases, 37 (6), 1195-1196. doi:10.1007/s10096-018-3233-7
Peer Reviewed verified by ORBi

Bakker, J., Balthazart, J., Baron, F., Beguin, Y., Bettendorff, L., Blanpain, C., Bureau, F., Caers, J., Cani, P., Cataldo, D., Cornil, C., Clercx, C., Cloots, R., Colige, A., Daube, G., De Backer, O., de Kerchove d'Exaerde, A., Desmecht, D., Desmet, C., ... Wittamer, V. (2018). La souris, le patient, et le faux expert. Décryptage d'une mystification. Le Vif. L'Express.

Rademaker, G., Hennequière, V., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Bettendorff, L., Deroanne, C., Thiry, M., Delvenne, P., Hustinx, R., Bellahcene, A., Castronovo, V., & Peulen, O. (April 2018). Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness. Oncogene, 37 ((32)), 4398-4412. doi:10.1038/s41388-018-0287-z
Peer Reviewed verified by ORBi

Blomme, A., van Simaeys, G., Doumont, G., Costanza, B., Bellier, J., Otaka, Y., Sherer, F., LOVINFOSSE, P., Boutry, S., Palacios, A. P., De Pauw, E., Hirano, T., Yokobori, T., Hustinx, R., Bellahcene, A., Delvenne, P., DETRY, O., Goldman, S., Nishiyama, M., ... Turtoi, A. (March 2018). Murine stroma adopts a human-like metabolic phenotype in the PDX model of colorectal cancer and liver metastases. Oncogene, 37 (9), 1237-1250. doi:10.1038/s41388-017-0018-x
Peer Reviewed verified by ORBi

Cambier, A., GIOT, J.-B., LEONARD, P., BLETARD, N., Meunier, P., Hustinx, R., Delwaide, J., MEURISSE, N., Honoré, P., Losson, B., Hayette, M.-P., & Detry, O. (March 2018). Prise en charge multidisciplinaire de l'echinococcose alveolaire : le groupe Echino-Liege. Revue Médicale de Liège, 73 (3), 135-142.
Peer reviewed

Salvé, M., Avohou, T. H., Monbaliu, J.-C., Lebrun, P., Lemaire, C., Damblon, C., De Tullio, P., Hubert, P., Hustinx, R., & Luxen, A. (12 February 2018). NOTA‐PRGD2 and NODAGA‐PRGD2: Bioconjugation, characterization, radiolabelling, and design space. Journal of Labelled Compounds and Radiopharmaceuticals, 61, 487-500. doi:10.1002/jlcr.3613
Peer Reviewed verified by ORBi

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., Bellier, J., Costanza, B., Herfs, M., Bettendorff, L., Deroanne, C., Delvenne, P., HUSTINX, R., Bellahcene, A., Castronovo, V., & Peulen, O. (2018). Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma and affects tumor aggressiveness [Poster presentation]. Bioforum Uliège.

Fosse, P., KAISER, M.-J., Namur, G., DE SENY, D., Malaise, M., & Hustinx, R. (2018). (18)F- FDG PET/CT joint assessment of early therapeutic response in rheumatoid arthritis patients treated with rituximab. European Journal of Hybrid Imaging, 2 (1), 6. doi:10.1186/s41824-017-0022-y
Peer Reviewed verified by ORBi

HUSTINX, R. (2018). Apport de la Médecine nucléaire dans l'évaluation du dommage corporel : Consilio Manuque. Revue Belge du Dommage Corporel et de Médecine Légale: Consilio Manuque, 2018/2, 55-62.
Peer reviewed

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Anania, S., Bettendorff, L., Deroanne, C., Thiry, M., Delvenne, P., HUSTINX, R., Bellahcene, A., Castronovo, V., & Peulen, O. (2018). Myoferlin controls mitochondrial structure and activity in pancreatic cancer and affects tumor aggressiveness [Poster presentation]. Belgian Association for Cancer Research Congress.

Cambier, A., Leonard, P., Losson, B., HAYETTE, M.-P., GIOT, J.-B., BLETARD, N., MEUNIER, P., HUSTINX, R., MEURISSE, N., DELWAIDE, J., Honoré, P., & DETRY, O. (January 2018). Alveolar echinococcosis is now endemic in southern Belgium. Acta Gastro-Enterologica Belgica, 81 (1), 31.
Peer Reviewed verified by ORBi

LOVINFOSSE, P., POLUS, M., VAN DAELE, D., Martinive, P., DAENEN, F., Hatt, M., Visvikis, D., KOOPMANSCH, B., LAMBERT, F., COIMBRA MARQUES, C., SEIDEL, L., Albert, A., Delvenne, P., & Hustinx, R. (2018). FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-017-3855-5
Peer Reviewed verified by ORBi

Amorim, C., Andris, F., Arckens, L., Arnould, T., Aron, S., Bakker, J., Balligand, M., Balthazart, J., Baron, F., Beck, B., Beguin, Y., Behets, C., Bellefroid, E., Bertrand, L., Bettendorff, L., Bindels, L., Blankert, B., Blanpain, C., Bondue, A., ... Wittamer, V. (2017). L’expérimentation animale reste indispensable (OPINION). La Libre Belgique.

Rinkin, C., Fosse, P., Hustinx, R., & Malaise, M. (November 2017). Tomographie à émission de positons par 18F-fluorodeoxyglucose dans la polyarthrite rhumatoïde : corrélation avec les scores cliniques d’activité. Revue du Rhumatisme, 84 (S1), 211.
Peer Reviewed verified by ORBi

HUSTINX, R. (October 2017). Le diagnostic de l'embolie pulmonaire. Pangea-ePatient, 1 (1), p. 29-31.

Rademaker, G., Hennequière, V., Brohée, L., Nokin, M.-J., LOVINFOSSE, P., Durieux, F., GOFFLOT, S., Bellier, J., Costanza, B., Herfs, M., Peiffer, R., Bettendorff, L., Deroanne, C., Delvenne, P., Hustinx, R., Bellahcene, A., Castronovo, V., & Peulen, O. (22 September 2017). Myoferlin controls mitochondrial structure in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness [Poster presentation]. Second U-CRC Symposium, Bruxelles, Belgium.

GANGOLF, M., DELGAUDINE, M., JACQUES, J., HUSTINX, R., KOLH, P., MEUNIER, P., VACCARELLA, S. (Other coll.), & LENAERTS, E. (Other coll.). (09 September 2017). Conception d’un tableau de bord stratégique : Application à l’activité du service de Radiodiagnostic du CHU de Liège [Paper presentation]. 28ème Congrès ALASS - Association Latine pour l'Analyse des Systèmes de Santé, Liège, Belgium.

MARCHETTA, S., WITHOFS, N., ERBA, P. A., HABIB, G., HUSTINX, R., & LANCELLOTTI, P. (August 2017). RADIONUCLIDE IMAGING OF INFECTIVE ENDOCARDITIS: state of art and future perspective. Current Cardiovascular Imaging Reports, 10 (27). doi:10.1007/s12410-017-9425-1
Peer reviewed

Liu, W., Delwaide, J., BLETARD, N., Delvenne, P., Meunier, P., Hustinx, R., & Detry, O. (April 2017). 18-Fluoro-deoxyglucose uptake in inflammatory hepatic adenoma: A case report. World Journal of Hepatology, 9 (11), 562-566. doi:10.4254/wjh.v9.i11.562
Peer Reviewed verified by ORBi

CHARLIER, E., NEUVILLE, S., RELIC, B., DEROYER, C., MALAISE, O., KURTH, W., GILLET, P., WITHOFS, N., HUSTINX, R., DE SENY, D., & MALAISE, M. (April 2017). Regulation of αVβ3 and αVβ5 integrin complexes by osteogenic differentiation of human hip OA chondrocytes [Poster presentation]. 2017 World Congress on Osteoarthritis.

Frangos, S., Hustinx, R., Boubaker, A., Varetto, T., Prior, J. O., Siroos, M., & Maffioli, L. (2017). The future of the past is the present. The challenge to educate Nuclear Medicine Specialist in present time. The important role of UEMS Section and European Board of Nuclear Medicine. Journal of Nuclear Medicine. doi:10.2967/jnumed.117.206052
Peer Reviewed verified by ORBi

Courtois, A., Nusgens, B., Garbacki, N., HUSTINX, R., Gomez, P., Defraigne, J.-O., Colige, A., & SAKALIHASAN, N. (2017). Circulating microRNAs signature correlates with positive [18F]fluorodeoxyglucose-positron emission tomography in patients with abdominal aortic aneurysm. Journal of Vascular Surgery. doi:10.1016/j.jvs.2016.12.112
Peer Reviewed verified by ORBi

Chiavarina, B., Nokin, M.-J., Bellier, J., Durieux, F., BLETARD, N., Sherer, F., LOVINFOSSE, P., Peulen, O., Verset, L., Dehon, R., Demetter, P., Turtoi, A., Uchida, K., Goldman, S., Hustinx, R., Delvenne, P., Castronovo, V., & Bellahcene, A. (2017). Methylglyoxal-Mediated Stress Correlates with High Metabolic Activity and Promotes Tumor Growth in Colorectal Cancer. International Journal of Molecular Sciences, 18 (1). doi:10.3390/ijms18010213
Peer Reviewed verified by ORBi

BRULS, S., Courtois, A., DELVENNE, P., HUSTINX, R., MOUTSCHEN, M., de Leval, L., Defraigne, J.-O., & SAKALIHASAN, N. (2017). IgG4-related disease causing rapid evolution of a severe aortic valvular stenosis. Annals of Thoracic Surgery. doi:10.1016/j.athoracsur.2016.08.045
Peer Reviewed verified by ORBi

Erpicum, P., HANSSEN, O., WEEKERS, L., LOVINFOSSE, P., Meunier, P., TSHIBANDA, L., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (2017). Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients, part II: omics analyses of urine and blood samples. NDT Plus, 1-10. doi:10.1093/ckj/sfw077
Peer Reviewed verified by ORBi

Thibaut, A., Moissenet, F., Di Perri, C., Schreiber, C., Remacle, A., Kolanowski, E., CHANTRAINE, F., BERNARD, C., HUSTINX, R., Tshibanda, J.-F., Filipetti, P., Laureys, S., & Gosseries, O. (2017). Brain plasticity after implanted peroneal nerve electrical stimulation to improve gait in chronic stroke patients: Two case reports. NeuroRehabilitation, 40 (2), 251-258. doi:10.3233/NRE-161410
Peer Reviewed verified by ORBi

MAGIS, D., D'Ostilio, K., Thibaut, A., De Pasqua, V., GERARD, P., HUSTINX, R., LAUREYS, S., & SCHOENEN, J. (2017). Cerebral metabolism before and after external trigeminal nerve stimulation in episodic migraine. Cephalalgia. doi:10.1177/0333102416656118
Peer Reviewed verified by ORBi

WITHOFS, N., COUSIN, F., DE PRIJCK, B., Bonnet, C., Hustinx, R., Gambhir, S. S., Beguin, Y., & Caers, J. (2017). A First Report on [(18)F]FPRGD2 PET/CT Imaging in Multiple Myeloma. Contrast Media and Molecular Imaging, 2017, 6162845. doi:10.1155/2017/6162845
Peer Reviewed verified by ORBi

JODOGNE, S., LENAERTS, E., MARQUET, L., ERPICUM, C., GREIMERS, R., GILLET, P., HUSTINX, R., & DELVENNE, P. (2017). Open Implementation of DICOM for Whole-Slide Microscopic Imaging. In Proceedings,- 12th International Joint Conference on Computer Vision, Imaging and Computer Graphics Theory and Applications (Volume 6) (pp. 81-87). doi:10.5220/0006155100810087
Peer reviewed

HANSSEN, O., Erpicum, P., LOVINFOSSE, P., Meunier, P., WEEKERS, L., TSHIBANDA, L., Krzesinski, J.-M., HUSTINX, R., & Jouret, F. (2017). Non-invasive approaches in the diagnosis of acute rejection in kidney transplant recipients. Part I. In vivo imaging methods. Clinical Kidney Journal, 10 (1), 97-105. doi:10.1093/ckj/sfw062
Peer Reviewed verified by ORBi

LOVINFOSSE, P., & HUSTINX, R. (2017). Nuclear Medicine techniques in transplantation. Clinical and Translational Imaging. doi:10.1007/s40336-016-0216-5
Peer reviewed

Verger, E., Drion, P., MEFFRE, G., BERNARD, C., Duwez, L., Lepareur, N., Couturier, O., Hindré, F., HUSTINX, R., & Lacoeuille, F. (2016). 68Ga and 188Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat Studies. PLoS ONE. doi:10.1371/journal.pone.0164626
Peer Reviewed verified by ORBi

PAQUES, F., HAMOIR, E., LOVINFOSSE, P., HUSTINX, R., & WITHOFS, N. (2016). A case of added value of 123I-mIBG SPECT/CT imaging in the diagnosis of a pheochromocytoma extending into the left adrenal vein. Acta Chirurgica Belgica. doi:10.1080/00015458.2016.1240917
Peer Reviewed verified by ORBi

NEUVILLE, M., Hustinx, R., JACQUES, J., Krzesinski, J.-M., & Jouret, F. (2016). Diagnostic Algorithm in the Management of Acute Febrile Abdomen in Patients with Autosomal Dominant Polycystic Kidney Disease. PLoS ONE. doi:10.1371/journal.pone.0161277
Peer Reviewed verified by ORBi

WITHOFS, N., COUSIN, F., TANCREDI, T., SIMONI, P., DE PRIJCK, B., HAFRAOUI, K., BONNET, C., HUSTINX, R., BEGUIN, Y., & CAERS, J. (14 June 2016). Comparison of combined whole-body 18F-NAF and 18F-FDG PET/CT versus MRI for the detection of myeloma lesions [Paper presentation]. SNMMI 2016 Annual Meeting.

Annen, J.* , Heine, L.* , Ziegler, E., Frasso, G., Bahri, M. A., Di Perri, C., Stender, J., Martial, C., Wannez, S., D'Ostilio, K., Amico, E., Antonopoulos, G., BERNARD, C., TSHIBANDA, L., HUSTINX, R., & Laureys, S. (06 June 2016). Function–structure connectivity in patients with severe brain injury as measured by MRI-DWI and FDG-PET. Human Brain Mapping, 37 (11), 3707-3720. doi:10.1002/hbm.23269
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Neuville, M., Hustinx, R., JACQUES, J., Krzesinski, J.-M., & Jouret, F. (23 May 2016). Diagnostic Management of Suspected Acute Cyst Complication in Patients with Autosomal Dominant Polycystic Kidney Disease [Poster presentation]. 53 rd congress ERA-EDTA, Vienna, Austria.

Verger, E., Drion, P., MEFFRE, G., BERNARD, C., Duwez, L., Lepareur, N., Couturier, O., Hindré, F., Lacoeuille, F., & HUSTINX, R. (01 May 2016). 188Re and 68Ga radiolabeled Starch-Based Microparticles as potential theranostic radiopharmaceutical for Hepatocellular Carcinoma. Journal of Nuclear Medicine, 57 (suppl. 2).
Peer Reviewed verified by ORBi

Verger, E., Drion, P., MEFFRE, G., BERNARD, C., Bouvier, A., Lepareur Nicolas, Couturier, O., Hindré, F., HUSTINX, R., & Lacoeuille, F. (May 2016). Microparticules à base d’amidon radiomarquées au 188Re et 68Ga comme agent théranostique pour la radiothérapie interne sélective du carcinome hépatocellulaire. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 40 (3), 182. doi:10.1016/j.mednuc.2016.03.035
Peer Reviewed verified by ORBi

Jadoul, A., LOVINFOSSE, P., WEEKERS, L., DELANAYE, P., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (28 April 2016). The Uptake of 18F-FDG by Renal Allograft in Kidney Transplant Recipients is not Influenced by Renal Function [Paper presentation]. Annual Meeting of the BVN-SBN, Bruxelles, Belgium.

Cottereau, A. S., Becker, S., Broussais, F., Casasnovas, O., Kanoun, S., Roques, M., Charrier, N., Bertrand, S., Delarue, R., Bonnet, C., Hustinx, R., Gaulard, P., de Leval, L., Vera, P., Itti, E., Mounier, N., Haioun, C., Tilly, H., & Meignan, M. (April 2016). Prognostic value of baseline total metabolic tumor volume (TMTV0) measured on FDG-PET/CT in patients with peripheral T-cell lymphoma (PTCL)†. Annals of Oncology, 27, 719-724. doi:10.1093/annonc/mdw011
Peer Reviewed verified by ORBi

WITHOFS, N., & HUSTINX, R. (19 February 2016). Integrin αvβ3 and RGD-based radiopharmaceuticals. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 40 (2016), 41-54. doi:10.1016/j.mednuc.2015.12.002
Peer Reviewed verified by ORBi

LOVINFOSSE, P., Janvary, Z. L., COUCKE, P., JODOGNE, S., BERNARD, C., Hatt, M., Visvikis, D., JANSEN, N., DUYSINX, B., & HUSTINX, R. (2016). FDG PET/CT texture analysis for predicting the outcome of lung cancer treated by stereotactic body radiation therapy. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-016-3314-8
Peer Reviewed verified by ORBi

WITHOFS, N., Martinive, P., VANDERICK, J., BLETARD, N., SCAGNOL, I., Mievis, F., Giacomelli, F., Coucke, P., Delvenne, P., Cataldo, D., Gambhir, S. S., & HUSTINX, R. (2016). [18F]FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-015-3219-y
Peer Reviewed verified by ORBi

Hustinx, R. (2016). How to scan who: the delicate balance between selecting the patient and selecting the imaging protocol. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-016-3511-5
Peer Reviewed verified by ORBi

LOVINFOSSE, P., KOOPMANSCH, B., LAMBERT, F., JODOGNE, S., KUSTERMANS, G., Hatt, M., Visvikis, D., SEIDEL, L., POLUS, M., Albert, A., DELVENNE, P., & HUSTINX, R. (2016). 18F-FDG PET/CT imaging in rectal cancer: relationship with the RAS mutational status. British Journal of Radiology, 20160212. doi:10.1259/bjr.20160212
Peer Reviewed verified by ORBi

Barrington, S. F., Fosse, P., WITHOFS, N., Itti, E., Hustinx, R., Couturier, O.-F., & Meignan, M. (2016). Recommendations to stage and assess the response to therapy of lymphomas with [18F]FDG-PET-CT. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 40 (1), 55 - 64. doi:10.1016/j.mednuc.2015.12.004
Peer Reviewed verified by ORBi

JADOUL, A., LOVINFOSSE, P., WEEKERS, L., DELANAYE, P., KRZESINSKI, J.-M., HUSTINX, R., & JOURET, F. (2016). The uptake of 18F-FDG by renal allograft in kidney transplant recipients is not influenced by renal function [Poster presentation]. LIII Congress of ERA-EDTA, Vienna, Austria.

LOVINFOSSE, P.* , Weekers, L.* , BONVOISIN, C., BOVY, C., GROSCH, S., Krzesinski, J.-M., Hustinx, R., & JOURET, F. (2016). Fluorodeoxyglucose F Positron Emission Tomography Coupled With Computed Tomography in Suspected Acute Renal Allograft Rejection. American Journal of Transplantation. doi:10.1111/ajt.13429
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Jadoul, A., LOVINFOSSE, P., WEEKERS, L., DELANAYE, P., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (2016). The Uptake of 18F-FDG by Renal Allograft in Kidney Transplant Recipients Is Not Influenced by Renal Function. Clinical Nuclear Medicine, 41 (9), 683-7. doi:10.1097/RLU.0000000000001298
Peer Reviewed verified by ORBi

Di Perri, C., Bahri, M. A., Amico, E., Thibaut, A., Heine, L., Antonopoulos, G., Charland-Verville, V., Wannez, S., Gomez, F., HUSTINX, R., TSHIBANDA, L., Demertzi, A.* , Soddu, A.* , & Laureys, S.*. (2016). Neural correlates of consciousness in patients who have emerged from a minimally conscious state: A cross-sectional multimodal imaging study. The Lancet Neurology, 15, 830-842. doi:10.1016/S1474-4422(16)00111-3
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Neuville, M., Hustinx, R., Krzesinski, J.-M., & Jouret, F. (09 October 2015). Diagnostic Management of Suspected Acute Cyst Complication in Patients with Autosomal Dominant Polycystic Kidney Disease [Poster presentation]. BENELUX kidney meeting, Eindhoven, Netherlands.

LOVINFOSSE, P., WEEKERS, L., BOVY, C., BONVOISIN, C., GROSCH, S., KRZESINSKI, J.-M., Hustinx, R., & Jouret, F. (13 September 2015). 18FDG-PET/CT IMAGING IN SUSPECTED ACUTE RENAL ALLOGRAFT REJECTION [Paper presentation]. 17th Congress of the European Society for Organ Transplantation, Brussels, Belgium.

WEEKERS, L., LOVINFOSSE, P., BONVOISIN, C., BOVY, C., GROSCH, S., Krzesinski, J.-M., Hustinx, R., & Jouret, F. (September 2015). Place de la tomographie à émission de positons au 18FDG couplée à la tomodensitométrie en cas de suspicion de rejet aigu du greffon rénal. Néphrologie et Thérapeutique, 11 (5), 280.
Peer Reviewed verified by ORBi

Antonopoulos, G., Wannez, S., Thibaut, A., Bahri, M. A., HUSTINX, R., BERNARD, C., Bruno, M.-A., Chatelle, C., Luxen, A., Phillips, C., Maquet, P., & Laureys, S. (22 June 2015). Diagnostic accuracy of cerebral metabolic imaging in disorders of consciousness [Poster presentation]. 1st Congress of the European Academy of Neurology 2015, Berlin, Germany.

Wannez, S., Thibaut, A., Vitali-Roscini, G., Di Perri, C., Bruno, M.-A., Chatelle, C., BERNARD, C., HUSTINX, R., MAQUET, P., Majerus, S., & Laureys, S. (21 June 2015). Recovery of language comprehension in the minimally conscious state studied by FDG-PET [Poster presentation]. 1st Congress of the European Academy of Neurology, Berlin, Germany.

Antonopoulos, G., Wannez, S., Thibaut, A., Bahri, M. A., HUSTINX, R., Bernard, C., Bruno, M.-A., Chatelle, C., Luxen, A., Phillips, C., & Laureys, S. (17 June 2015). Automatic Classification of FDG-PET imaging data in Disorders of Consciousness [Poster presentation]. 21 ST ANNUAL MEETING OF THE ORGANIZATION FOR HUMAN BRAIN MAPPING, Honolulu, Hawaii, United States.

Annen, J., Heine, L., Ziegler, E., Stender, J., Bahri, M. A., Wannez, S., Bruno, M.-A., Thibaut, A., BERNARD, C., Antonopoulos, G., Di Perri, C., Martial, C., Amico, E., Demertzi, A., Salmon, E., Maquet, P., TSHIBANDA, L., HUSTINX, R., & Laureys, S. (June 2015). Multimodal characterization of default mode network structure and metabolism in patients with disorders of consciousness using diffusion weighted-MRI and 18F-FDG-PET [Poster presentation]. 1st Congress of the European Academy of Neurology, Berlin, Germany.
Peer reviewed

DUYSINX, B., & HUSTINX, R. (April 2015). Imagerie métabolique en oncologie thoracique. EMC - Pneumologie, 12 (2).
Peer reviewed

Detry, O., Govaerts, L., De Roover, A., VANDERMEULEN, M., MEURISSE, N., Malenga, BLETARD, N., Mbendi, C., LAMPROYE, A., Honoré, P., MEUNIER, P., Delwaide, J., & Hustinx, R. (14 March 2015). Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma. World Journal of Gastroenterology, 21 (10), 3049-54. doi:10.3748/wjg.v21.i10.3049
Peer Reviewed verified by ORBi

WITHOFS, N., SIGNOLLE, N., SOMJA, J., LOVINFOSSE, P., MUTIJIMA NZARAMBA, E., Mievis, F., Giacomelli, F., WALTREGNY, D., CATALDO, D., GAMBHIR, S. S., & HUSTINX, R. (2015). 18F-FPRGD2 PET/CT imaging of integrin αvβ3 in renal carcinomas: Correlation with histopathology. Journal of Nuclear Medicine. doi:10.2967/jnumed.114.149021
Peer Reviewed verified by ORBi

COOK, G., & HUSTINX, R. (2015). Challenges for imaging and therapy of musculoskeletal tumours. Clinical and Translational Imaging. doi:10.1007/s40336-015-0111-5
Peer reviewed

Bretin, F., Bahri, M. A., BERNARD, C., Warnock, G., Aerts, J., Mestdagh, N., Buchanan, T., Otoul, C., Koestler, F., Mievis, F., Giacomelli, F., Degueldre, C., Hustinx, R., Luxen, A., Seret, A., Plenevaux, A., & Salmon, E. (17 January 2015). Biodistribution and radiation dosimetry for the novel SV2A radiotracer [18F]UCB-H: First-in-human study. Molecular Imaging and Biology, 17, 557-564. doi:10.1007/s11307-014-0820-6
Peer Reviewed verified by ORBi

SAKALIHASAN, N., NIENABER, C., HUSTINX, R., LOVINFOSSE, P., EL HACHEMI, M., CHERAMY-BIEN, J.-P., SEIDEL, L., LAVIGNE, J.-P., QUANIERS, J., KERSTENNE, M.-A., Courtois, A., OOMS, A., Albert, A., Defraigne, J.-O., & Michel, J.-B. (2015). (Tissue PET) vascularmetabolic imaging and peripheral plasma biomarkers in the evolution of chronic aortic dissections. European Heart Journal. Cardiovascular Imaging. doi:10.1093/ehjci/jeu283
Peer Reviewed verified by ORBi

Verger, E., Cikankowitz, A., Bouvier, A., Lepareur, N., Benoit, J.-P., Deloye, J.-B., Aubé, C., Couturier, O., Lacoeuille, F., Hustinx, R., & Hindré, F. (2015). A theranostic tool for Hepatocellular carcinoma: the Starch-Based Microparticles [Paper presentation]. 3rd Nuclear Technologies for Health Symposium, Nantes, France.

Thibaut, A., Di Perri, C., Chatelle, C., Bruno, M.-A., Bahri, M. A., Wannez, S., Piarulli, A., BERNARD, C., Martial, C., Heine, L., HUSTINX, R., & Laureys, S. (2015). Clinical Response to tDCS Depends on Residual Brain Metabolism and Grey Matter Integrity in Patients With Minimally Conscious State. Brain Stimulation, 8 (6), 1116-23. doi:10.1016/j.brs.2015.07.024
Peer Reviewed verified by ORBi

Bruls, S.* , Courtois, A.* , Nusgens, B., Defraigne, J.-O., Delvenne, P., Hustinx, R., Moutschen, M., & SAKALIHASAN, N. (2015). 18F-FDG PET/CT in the Management of Aortitis. Clinical Nuclear Medicine. doi:10.1097/RLU.0000000000001016
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Barrington, S. F., Mikhaeel, N. G., Kostakoglu, L., Meignan, M., Hutchings, M., Mueller, S., Schwartz, L. H., Zucca, E., Fisher, R. I., Trotman, J., Hoekstra, O. S., Hicks, R. J., O'Doherty, M. J., HUSTINX, R., Biggi, A., Cavalli, F., Lister, T. A., & Cheson, B. D. (2015). Reply to B. Bennani-Baiti et al, H.J.A. Adams et al, E. Laffon et al, and E.A. Hawkes et al. Journal of Clinical Oncology, 33 (10), 1221-3. doi:10.1200/JCO.2014.59.9373
Peer Reviewed verified by ORBi

WITHOFS, N., CHARLIER, E., Simoni, P., Alvarez-Miezentseva, V., Mievis, F., Giacomelli, F., Mella, C., Gambhir, S. S., Malaise, O., DE SENY, D., MALAISE, M., & HUSTINX, R. (2015). (18)F-FPRGD2 PET/CT imaging of musculoskeletal disorders. Annals of Nuclear Medicine, 29 (10), 839-47. doi:10.1007/s12149-015-1011-5
Peer Reviewed verified by ORBi

Barrington, S. F., Mikhaeel, N. G., Kostakoglu, L., Meignan, M., Hutchings, M., Mueller, S., Schwartz, L. H., Zucca, E., Fisher, R. I., Trotman, J., Hoekstra, O. S., Hicks, R. J., O'Doherty, M. J., HUSTINX, R., Biggi, A., & Cheson, B. D. (2015). Reply to G. Keramida et al. Journal of Clinical Oncology, 33 (34), 4121-2. doi:10.1200/JCO.2015.63.2125
Peer Reviewed verified by ORBi

Courtois, A., Nusgens, B., HUSTINX, R., Defraigne, J.-O., Colige, A., & SAKALIHASAN, N. (2015). Circulating miRNA signature of PET-positive abdominal aortic aneurysms: new potential predictors of rupture. Arteriosclerosis, Thrombosis and Vascular Biology.
Peer Reviewed verified by ORBi

PRIGENT, A., HUSTINX, R., & COSTA, D. C. (2015). Nuclear medicine training in the European Union : 2015 Update. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-015-3244-x
Peer Reviewed verified by ORBi

Stender, J., Kupers, R., Rodell, A., Thibaut, A., Chatelle, C., Bruno, M.-A., Gejl, M., Bernard, C., HUSTINX, R., Laureys, S., & Gjedde, A. (2015). Quantitative rates of brain glucose metabolism distinguish minimally conscious from vegetative state patients. Journal of Cerebral Blood Flow and Metabolism, 35 (1), 58-65. doi:10.1038/jcbfm.2014.169
Peer Reviewed verified by ORBi

Salmon, E., Bernard, C., & HUSTINX, R. (2015). Pitfalls and Limitations of PET/CT in Brain Imaging. Seminars in Nuclear Medicine, 45 (6), 541-51. doi:10.1053/j.semnuclmed.2015.03.008
Peer Reviewed verified by ORBi

Courtois, A., Nusgens, B., HUSTINX, R., Namur, G., Gomez, P., Kuivaniemi, H., Defraigne, J.-O., Colige, A., & SAKALIHASAN, N. (2015). Gene Expression Study in Positron Emission Tomography–Positive Abdominal Aortic Aneurysms Identifies CCL18 as a Potential Biomarker for Rupture Risk. Molecular Medicine. doi:10.2119/molmed.2014.00065
Peer reviewed

HATT, M., MAJDOUB, M., VALLIERES, M., TIXIER, F., CHEZE LE REST, C., GROHEUX, D., HINDIE, E., MARTINEAU, A., PRADIER, O., HUSTINX, R., PERDRISOT, R., GUILLEVIN, R., EL NAQA, I., & VISVIKIS, D. (January 2015). 18F-FDG PET Uptake Characterization Through Texture Analysis: Investigating the Complementary Nature of Heterogeneite and Functional Tumor Volume in a Multi-Cancer Site Patient Cohort. Journal of Nuclear Medicine, 56 (1), 38-44. doi:10.2967/jnumed.114.144055
Peer Reviewed verified by ORBi

JODOGNE, S., LENAERTS, E., COUCKE, P., & HUSTINX, R. (26 November 2014). Orthanc - Free and Open-Source Software for Medical Imaging in Hospitals [Poster presentation]. BioWin Day 2014, Louvain-la-Neuve, Belgium.

Verger, E., Bouvier, A., Benoit, J.-P., Aubé, C., Couturier, O., HUSTINX, R., Lacoeuille, F., & Hindré, F. (October 2014). Radiolabelling of starch microparticles with Rhenium-188 for hepatocellular carcinoma’s therapy. European Journal of Nuclear Medicine and Molecular Imaging, 41 (Supplement 2), 443-S444. doi:10.1007/s00259-014-2901-9
Peer Reviewed verified by ORBi

MEURISSE, N., DETRY, O., Govaerts, L., DE ROOVER, A., VANDERMEULEN, M., Malenga, S., BLETARD, N., Mbendi, C., LAMPROYE, A., HONORE, P., MEUNIER, P., Delwaide, J., & HUSTINX, R. (September 2014). Prognostic value of (18)F-FDG PET/CT in liver transplantation for hepatocarcinoma. Transplant International, 27 (S2), 18 (EP-17.
Peer Reviewed verified by ORBi

BARRINGTON, S. F., MIKKHAEEL, N. G., KOSTAKOGLU, L., MEIGNAN, M., HUTCHINGS, M., MUELLER, S. P., SCHWARTZ, L. H., ZUCCA, E., FISHER, R. I., TROTMAN, J., HOEKSTRA, O. S., HICKS, R. J., O'DOHERTY, M. J., HUSTINX, R., BIGGI, A., & CHESON, B. D. (2014). Role of Imaging in the Staging and Response Assessment of Lymphoma : Consensus of the International Conference on Malignant Lymphomas Imaging Working Group. Journal of Clinical Oncology. doi:10.1200/JCO.2013.53.5229
Peer Reviewed verified by ORBi

JODOGNE, S., LENAERTS, E., COUCKE, P., & HUSTINX, R. (2014). Orthanc - Logiciel libre pour l'imagerie médicale en milieu hospitalier. In Communications de la Conférence Francophone en Gestion et Ingénierie des Systèmes Hospitaliers (GISEH 2014).
Peer reviewed

CAERS, J., WITHOFS, N., Hillengass, J., SIMONI, P., Zamagni, E., HUSTINX, R., & BEGUIN, Y. (April 2014). The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow-up of multiple myeloma. Haematologica, 99 (4), 629-37. doi:10.3324/haematol.2013.091918
Peer Reviewed verified by ORBi

DETRY, O., Govaerts, L., BLETARD, N., MEURISSE, N., Verset, G., DE ROOVER, A., DELWAIDE, J., LAMPROYE, A., HONORE, P., & HUSTINX, R. (March 2014). Prognostic value of FDG PET/CT in liver transplantation for hepatocarcinoma. Acta Gastro-Enterologica Belgica, 77 (1), 08.
Peer Reviewed verified by ORBi

WITHOFS, N., & HUSTINX, R. (2014). Imagerie de l'intégrine αvβ3 par PET/CT au 18F-FPRGD2. Revue Médicale de Liège, 69 (Synthèse 2014), 36-40.
Peer reviewed

WITHOFS, N., BERNARD, C., VAN DER REST, C., MARTINIVE, P., HATT, M., JODOGNE, S., VISVIKIS, D., LEE, J. A., COUCKE, P., & HUSTINX, R. (2014). FDG PET/CT for rectal carcinoma radiotherapy treatment planning : Comparison of functional volume delineation algorithms and clinical challenges. Journal of Applied Clinical Medical Physics, 15 (5), 216-228. doi:10.1120/jacmp.v15i5.4696
Peer Reviewed verified by ORBi

LALLEMAND, F., LAKOSI, F., HUSTINX, R., WITHOFS, N., MEUNIER, P., TSHIBANDA, L., JODOGNE, S., COUCKE, P., & MARTINIVE, P. (2014). Utilisation de l'imagerie fonctionnelle en radiothérapie. Revue Médicale de Liège, 69 (Supp 1), 20-28.
Peer reviewed

MEURISSE, N., DETRY, O., GOVAERTS, L., DE ROOVER, A., VANDERMEULEN, M., MALENGA, BLETARD, N., MBENDI, C., LAMPROYE, A., HONORE, P., MEUNIER, P., DELWAIDE, J., & HUSTINX, R. (2014). Prognostic value of 18f-fdg PET - CT in liver transplantation for hepatocarcinoma [Poster presentation]. 8 th ELITA ELTR MEETING, Prague, Czechia.

BECKERS, C., & Hustinx, R. (2014). SPECT/CT workflow and imaging protocols. European Journal of Nuclear Medicine and Molecular Imaging, 41, 137-S145. doi:10.1007/s00259-013-2629-y
Peer Reviewed verified by ORBi

Verger, E., Bouvier, A., Benoit, J.-P., Couturier, O., HUSTINX, R., Lacoeuille, F., & Hindré, F. (2014). Radiomarquage au 188Re des microparticules à base d’amidon pour la thérapie du carcinome hépatocellulaire [Poster presentation]. 8èmes Journées Cancéropole Grand Ouest, Les Sables-d’Olonne, France.

Thibaut, A., Chatelle, C., Stender, J., Demertzi, A., BERNARD, C., HUSTINX, R., LAUREYS, S., & Bruno, M.-A. (2014). Positron emission tomography imaging in altered states of consciousness: Coma, sleep and hypnosis. In R. Dierckx, A. Otte, E. Vries, A. Waarde, ... K. Leenders (Eds.), PET and SPECT in Neurology (pp. 965-986). Paris, France: Springer.
Peer reviewed

Courtois, A., Namur, G., EL HACHEMI, M., Creemers, E., Nusgens, B., HUSTINX, R., Allaire, E., Defraigne, J.-O., Colige, A., & SAKALIHASAN, N. (2014). Uptake of FDG detected by positron emission tomography in the abdominal aortic aneurysm is correlated with endoleaks and predicts the adverse outcome of AAA after endovascular aortic repair [Poster presentation]. 4th International meeting on aortic disease.

Courtois, A., Nusgens, B., Hustinx, R., Gomez, P., Defraigne, J.-O., Colige, A., & SAKALIHASAN, N. (2014). Intérèts de la tomographie à émission de positons dans le suivi et le pronostic des anévrysmes de l'aorte abdominale. Revue Médicale de Liège, 69 Spec No, 12-8.
Peer reviewed

DELANAYE, P., BECKERS, C., & HUSTINX, R. (2014). Le néphrogramme isotopique (méthode de “Gates”) permet-il une estimation correcte du débit de filtration glomérulaire ? Revue de la littérature [Poster presentation]. XVI réunion commune de la société de Néphrologie et de la société Francophone de Dialyse, Saint-Etienne, France.

Verger, E., Cikankowitz, A., Bouvier, A., Lepareur, N., Benoit, J.-P., Deloye, J.-B., Aubé, C., Couturier, O., Lacoeuille, F., HUSTINX, R., & Hindré, F. (2014). Development of a new selective internal radiation therapy and diagnostic tool for hepatocellular carcinoma: the starch-based microspheres [Poster presentation]. 3rd NanoFar Autumn School, Bruxelles, Belgium.

Verger, E., Cikankowitz, A., Bouvier, A., Lepareur, N., Benoit, J.-P., Deloye, J.-B., Aubé, C., Couturier, O., Lacoeuille, F., HUSTINX, R., & Hindré, F. (2014). Starch based microparticles radiolabelling with 99mTc and 188Re for diagnostic and therapy of Hepatocellular carcinoma [Paper presentation]. 8th International Symposium on Technetium and Rhenium, Pornichet La Baule, France.

BISOGNI, C., MEURISSE, M., BETEA, D., & HUSTINX, R. (2014). L'image du mois : une parathyroïde ectopique. Revue Médicale de Liège, 69 (9), 473-475.
Peer reviewed

Courtois, A., Nusgens, B., Hustinx, R., Defraigne, J.-O., Colige, A., & Sakalihasan, N. (2014). Circulating microRNA expression signature in PET positive abdominal aortic aneurysms: new potential biomarkers. Aorta.
Peer reviewed

SABOURY, B., SALAVATI, A., BROTHERS, A., BASU, S., KWEE, T., LAM, M., HUSTINX, R., LOUIS, E., TORIGIAN, D., & ALAVI, A. (2014). FDG PET/CT in Crohn's disease : correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity. European Journal of Nuclear Medicine and Molecular Imaging, 41, 605-614. doi:10.1007/s00259-013-2625-2
Peer Reviewed verified by ORBi

Chatelle, C., Thibaut, A., Bruno, M.-A., Boly, M., Bernard, C., Hustinx, R., Schnakers, C., & Laureys, S. (2014). Nociception coma scale-revised scores correlate with metabolism in the anterior cingulate cortex. Neurorehabilitation and Neural Repair, 28 (2), 149-52. doi:10.1177/1545968313503220
Peer Reviewed verified by ORBi

Chatelle, C.* , Thibaut, A.* , Gosseries, O., Bruno, M.-A., Demertzi, A., BERNARD, C., HUSTINX, R., TSHIBANDA, L., Bahri, M. A., & Laureys, S. (2014). Changes in cerebral metabolism in patients with a minimally conscious state responding to zolpidem. Frontiers in Neuroscience, 8, 917. doi:10.3389/fnhum.2014.00917
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Courtois, A., Nusgens, B., Hustinx, R., Namur, G., Gomez, P., Somja, J., Defraigne, J.-O., Delvenne, P., Michel, J.-B., Colige, A., & Sakalihasan, N. (05 September 2013). 18F-FDG Uptake Assessed by PET/CT in Abdominal Aortic Aneurysms Is Associated with Cellular and Molecular Alterations Prefacing Wall Deterioration and Rupture. Journal of Nuclear Medicine, 54, 1740-1747. doi:10.2967/jnumed.112.115873
Peer Reviewed verified by ORBi

GOVAERTS, L., DETRY, O., BLETARD, N., VERSET, G., HONORE, P., DE ROOVER, A., DELWAIDE, J., & HUSTINX, R. (2013). The prognostic value of preoperative FDG PET-CT in hepatocellular carcinoma treated by liver transplantation. In PROCEEDINGS OF THE XVIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE.
Peer reviewed

Charland-Verville, V., Bruno, M.-A., Bahri, M. A., Demertzi, A., Desseilles, M., Chatelle, C., Vanhaudenhuyse, A., HUSTINX, R., BERNARD, C., TSHIBANDA, L., Laureys, S., & Zeman, A. (12 April 2013). Brain dead yet mind alive: A positron emission tomography case study of brain metabolism in Cotard’s syndrome. Cortex: A Journal Devoted to the Study of the Nervous System and Behavior, 49 (7), 1997-1999. doi:10.1016/j.cortex.2013.03.003
Peer Reviewed verified by ORBi

Bernard, C., Paulus, C., JODOGNE, S., & Hustinx, R. (2013). Automated platform for the quality control of PET-CT scanners following AFCN/FANC recommendations. In Proceedings of the Belgian Hospital Physicists Association Symposium.
Peer reviewed

Verger, E., Belloche, C., Cikankowitz, A., Roux, J., Lacoeuille, F., Couturier, O., HUSTINX, R., & Hindré, F. (2013). Nanomedicines and micromedicines for vectorised radiotherapy of Hepatocellular Carcinoma [Poster presentation]. 2nd NanoFar Autumn School, Santiago de Compostella, Spain.

WITHOFS, N., ALVAREZ MIEZENTSEVA, V., SIMONI, P., Luxen, A., GAMBHIR, S., & HUSTINX, R. (2013). Imaging osteoarthritis using (18F)FPRGD2 PET/CT : observation and potential application. Journal of Nuclear Medicine, 54 (SUPPL), 250.
Peer Reviewed verified by ORBi

Garraux, G.* , Phillips, C.* , Schrouff, J., Kreisler, A., Lemaire, C., Degueldre, C., Delcour, C., Hustinx, R., Luxen, A., Destée, A., & Salmon, E. (2013). Multiclass classification of FDG PET scans for the distinction between Parkinson's disease and atypical parkinsonian syndromes. NeuroImage: Clinical, 2, 883-893. doi:10.1016/j.nicl.2013.06.004
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

COUSIN, F., Alvarez, V., BECKERS, C., Hustinx, R., & SIMONI, P. (2013). L'image du mois: La myosite ossifiante neurogene. Revue Médicale de Liège, 68 (2), 53-5.
Peer reviewed

GOVAERTS, L., DETRY, O., BLETARD, N., VERSET, G., HONORE, P., DE ROOVER, A., DELWAIDE, J., & HUSTINX, R. (2013). Prognostic value of FDG PET/CT in patients with hepatocellular carcinoma treated with liver transplantation. European Journal of Nuclear Medicine and Molecular Imaging, 2013 (SUPPL), 287.
Peer Reviewed verified by ORBi

LOVINFOSSE, P., JANVARY, Z. L., JANSEN, N., DISTER, F., FRUSCH, N., DUYSINX, B., COUCKE, P., & HUSTINX, R. (2013). Prognostic value of FDG PET/CT in patients with lung tumors treated by Cyberknife. Journal of Nuclear Medicine, 54 (SUPPL), 567.
Peer Reviewed verified by ORBi

Hauzeur, J.-P., Bernard, C., Egrise, D., Kurth, W., Van Cauwenberge, H., LECHANTEUR, C., Gillet, P., Beguin, Y., MALAISE, M., & HUSTINX, R. (2013). (111)Indium-oxine labelling for evaluating the homing process of autologous osteoblasts implanted percutaneously in atrophic nonunion fractures. International Orthopaedics, 37 (1), 131-6. doi:10.1007/s00264-012-1719-y
Peer Reviewed verified by ORBi

Verger, E., Lacoeuille, F., Couturier, O., HUSTINX, R., & Hindré, F. (2013). Nanomédecines et micromédecines pour la radiothérapie vectorisée appliquée au traitement du Carcinome Hepato-Cellulaire [Poster presentation]. 7èmes Journées du Cancéropole Grand Ouest, Les Sables d'Olonne, France.

HUSTINX, R. (October 2012). Newer Methods for Improving Yield from FDG-PET Imaging for Accurate Staging, Determining Tumor Biology, and Assessing Prognosis. PET Clinics, 7 (4), 425-430. doi:10.1016/j.cpet.2012.06.005
Peer Reviewed verified by ORBi

MAGIS, D., Bruno, M.-A., FUMAL, A., Gerardy, P.-Y., HUSTINX, R., LAUREYS, S., & Schoenen, J. (2012). Cluster headache Award 2012: Central modulation in cluster headache patients treated with occipital nerve stimulation. Journal of Headache and Pain.
Peer Reviewed verified by ORBi

VALDES SOCIN, H. G., BISOGNI, C., BETEA, D., Lillet, H., SCAGNOL, I., Hustinx, R., HAMOIR, E., Meurisse, M., & Beckers, A. (2012). Primary hyperparathyroidism confirmed by histology : sensitivity and predictors of 99mTc-Sestamibi/CT scan. In Abstract Book - 13th International Workshop on Multiple Endocrine Neoplasia.

Thibaut, A., Bruno, M.-A., Chatelle, C., Gosseries, O., Vanhaudenhuyse, A., Demertzi, A., Schnakers, C., Thonnard, M., CHARLAND-VERVILLE, V., BERNARD, C., Bahri, M. A., Phillips, C., Boly, M., Hustinx, R., & Laureys, S. (2012). Metabolic activity in external and internal awareness networks in severely brain-damaged patients. Journal of Rehabilitation Medicine, 44 (6), 487-94. doi:10.2340/16501977-0940
Peer Reviewed verified by ORBi

MINON, A., CABAY, J.-E., DEMEZ, P., Bernard, C., MOREAU, P., & HUSTINX, R. (2012). Nodal staging of head and neck squamous cell carcinomas : impact of a dedicated PET/CT protocol. Journal of Nuclear Medicine, 53 (SUPPL), 1354.
Peer Reviewed verified by ORBi

WITHOFS, N., SIGNOLLE, N., NZARAMBA, E., THONON, D., LEONARD, M., AERTS, J., WALTREGNY, D., CATALDO, D., GAMBHIR, S., & HUSTINX, R. (2012). (18F)FPRGD2 PET/CT imaging of integrin αvβ3 in renal carcinomas : correlation with histopathology. Journal of Nuclear Medicine, 53 (SUPPL), 1647.
Peer Reviewed verified by ORBi

Chatelle, C., Thibaut, A., Gosseries, O., Thonnard, M., BERNARD, C., HUSTINX, R., LAUREYS, S., & Bruno, M.-A. (2012). Zolpidem effect on recovery of consciousness: a FDG-PET study [Poster presentation]. Belgian Brain Congress, Liège, Belgium.

Bruno, M.-A., Majerus, S., Boly, M., Vanhaudenhuyse, A., Schnakers, C., Gosseries, O., Boveroux, P., KIRSCH, M., Demertzi, A., Bernard, C., Hustinx, R., Moonen, G., & Laureys, S. (2012). Functional neuroanatomy underlying the clinical subcategorization of minimally conscious state patients. Journal of Neurology, 259 (6), 1087-98. doi:10.1007/s00415-011-6303-7
Peer Reviewed verified by ORBi

Govaerts, L., WITHOFS, N., DURIEUX, R., Spote, V., & Hustinx, R. (2012). Acute intramural haematoma of the ascending aorta. European Journal of Nuclear Medicine and Molecular Imaging, 39 (8), 1368-9. doi:10.1007/s00259-012-2130-z
Peer Reviewed verified by ORBi

WITHOFS, N., MARTINIVE, P., SCAGNOL, I., THONON, D., Giacomelli, F., Mievis, F., COUCKE, P., CATALDO, D., Gambhir, S., & HUSTINX, R. (2012). Preliminary results of (18F)FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinoma. Journal of Nuclear Medicine, 53 (SUPPL), 1703.
Peer Reviewed verified by ORBi

HUSTINX, R. (2012). PET-CT and PET-MRI in Oncology, A practical Guide: Gastrointestinal (135-159). In P. PELLER, R. SUBRAMANIAM, ... A. GUERMAZI (Eds.), MEDICAL RADIOLOGY - DIAGNOSIS IMAGING : PET-CT and PET-MRI in Oncology - A pratical Guide (pp. 135-159). Springer. doi:10.1007/174_2011_432
Peer reviewed

VAN DER REST, C., CAVALIER, E., KAUX, J.-F., KRZESINSKI, J.-M., HUSTINX, R., REGINSTER, J.-Y., & DELANAYE, P. (October 2011). Tumor-induced osteomalacia: The tumor may stay hidden! Clinical Biochemistry, 44 (14-15), 1264-6. doi:10.1016/j.clinbiochem.2011.07.013
Peer Reviewed verified by ORBi

VAN DER REST, C., CAVALIER, E., COLSON, L., KAUX, J.-F., KRZESINSKI, J.-M., REGINSTER, J.-Y., HUSTINX, R., & DELANAYE, P. (August 2011). Hypophosphatémie et ostéomalacie oncogénique. Revue Médicale Suisse, 7, 1630-3.
Peer Reviewed verified by ORBi

Seret, A., Nguyen, D., HUSTINX, R., & BERNARD, C. (07 May 2011). Potentialités quantitatives et qualité d'image de la camera TEMP/TDM Siemens Symbia T6. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 35, 289.
Peer Reviewed verified by ORBi

MAGIS, D., Bruno, M.-A., FUMAL, A., Gerardy, P.-Y., HUSTINX, R., LAUREYS, S., & Schoenen, J. (24 February 2011). Central modulation in cluster headache patients treated with occipital nerve stimulation: an FDG-PET study. BMC Neurology, 11, 25. doi:10.1186/1471-2377-11-25
Peer Reviewed verified by ORBi

COURTOIS, A., Nusgens, B., Defraigne, J.-O., Hustinx, R., Gomez, P., Somja, J., Delvenne, P., Colige, A., & SakalihasanN, N. (2011). Uptake of 18-FDG as detected by positron emission tomography is correlated to an increased inflammatory infiltrate and expression of proteolytic enzymes in abdominal aortic aneurysm wall [Poster presentation]. The leucocyte in cardiovascular disease conference, Geneva, Switzerland.

Withofs, N., Grayet, B., Tancredi, T., Rorive, A., Mella, C., Giacomelli, F., Mievis, F., Aerts, J., Waltregny, D., Jerusalem, G., & Hustinx, R. (2011). 18F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers. Nuclear Medicine Communications, 32 (3), 168-176. doi:10.1097/MNM.0b013e3283412ef5
Peer Reviewed verified by ORBi

Pourdehnad, M., Basu, S., Duarte, P., Okpaku, A. S., Saboury, B., HUSTINX, R., & Alavi, A. (2011). Reduced grey matter metabolism due to white matter edema allows optimal assessment of brain tumors on 18F-FDG-PET. Hellenic Journal of Nuclear Medicine, 14 (3), 219-23.
Peer Reviewed verified by ORBi

MINON, A., DEMEZ, P., MOREAU, P., RANSY, P., LEFEBVRE, P., & HUSTINX, R. (2011). Efficacy of FDG PET/CT for diagnosing synchronous tumors and metastases in head and neck tumors : Initial results and evaluation. Journal of Nuclear Medicine, 52 (SUPPL), 1863.
Peer Reviewed verified by ORBi

SABOURY, B., HUSTINX, R., BROTHERS, B., FOROUGHI, N., HOFHEINZ, F., TARIGIAN, D., & ALAVI, A. (2011). Assessment of Crohn’s disease activity by FDG-PET/CT through a novel quantitative approach. Journal of Nuclear Medicine, 52 (SUPPL), 284.
Peer Reviewed verified by ORBi

Thonon, D., Goblet, D., Goukens, E., Kaisin, G., Paris, J., Aerts, J., Lignon, S., Franci, X., Hustinx, R., & Luxen, A. (2011). Fully Automated Preparation and Conjugation of N-Succinimidyl 4-[(18)F]Fluorobenzoate ([ (18)F]SFB) with RGD Peptide Using a GE FASTlab Synthesizer. Molecular Imaging and Biology. doi:10.1007/s11307-011-0470-x
Peer Reviewed verified by ORBi

THULKAR, NAMUR, G., HUSTINX, R., BHALLA, A. S., & KUMAR, R. (2011). Multimodality staging of lung cancer. PET Clinics, 6, 251-263. doi:10.1016/j.cpet.2011.05.001
Peer Reviewed verified by ORBi

Phillips, C., Bruno, M.-A., Maquet, P., Boly, M., Noirhomme, Q., Schnakers, C., Vanhaudenhuyse, A., Bonjean, M., Hustinx, R., Moonen, G., Luxen, A., & Laureys, S. (2011). "Relevance vector machine" consciousness classifier applied to cerebral metabolism of vegetative and locked-in patients. NeuroImage, 56 (2), 797–808. doi:10.1016/j.neuroimage.2010.05.083
Peer Reviewed verified by ORBi

WITHOFS, N., Bernard, C., VAN DER REST, C., MARTINIVE, P., HATT, M., Dimitris, V., COUCKE, P., & HUSTINX, R. (2011). FDG PET/CT for radiotherapy treatment planning. Comparison of functional volume delineation algorithms. Journal of Nuclear Medicine.
Peer reviewed

WITHOFS, N., COLLIGNON, J., & HUSTINX, R. (2011). Imagerie des métastases osseuses du cancer du sein. Revue Médicale de Liège, 66 (5-6), 291-298.
Peer reviewed

Bruno, M.-A.* , Gosseries, O.* , Ledoux, D., Hustinx, R., & Laureys, S. (2011). Assessment of consciousness with electrophysiological and neurological imaging techniques. Current Opinion in Critical Care. doi:10.1097/MCC.0b013e328343476d
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

AGIUS, C., NAMUR, G., COUTURIER, O., & HUSTINX, R. (2011). 2-18F-Fluoro-L-tyrosine in the suspicion of recurrence of previously treated gliomas. European Journal of Nuclear Medicine and Molecular Imaging, 38 (SUPPL), 219.
Peer Reviewed verified by ORBi

WITHOFS, N., COLLIGNON, J., RORIVE, A., JERUSALEM, G., & HUSTINX, R. (2011). Hétérogénéité des métastases osseuses du cancer du sein : cas clinique illustrant l'intérêt de combiner différentes techniques d'imagerie. Revue Médicale de Liège, 66 (5-6), 288-290.
Peer reviewed

BERNARD, C., HAUZEUR, J.-P., LECHANTEUR, C., VAN CAUWENBERGE, H., BEGUIN, Y., MALAISE, M., KURTH, W., GILLET, P., & HUSTINX, R. (2011). Evaluation of the homing process in the treatment of atrophic nonunion fractures by percutaneous autologous osteoblast cell implantation. Journal of Nuclear Medicine, 52 (SUPPL), 510.
Peer Reviewed verified by ORBi

Cusumano, P., BLERET, V., Nos, C., Hustinx, R., LILET, H., Gomez, P., & LIFRANGE, E. (2011). Ganglion sentinelle et sentibras: pour un "staging" axillaire sur mesure. Revue Médicale de Liège, 66 (5-6), 336-40.
Peer reviewed

DEMONTY, J., GONCE, M., Ribai, P., Verellen-Dumoulin, C., & Hustinx, R. (2010). Chorea associated with anti-phospholipid antibodies: case report. Acta Clinica Belgica, 65 (5), 350-3. doi:10.1179/acb.2010.075
Peer Reviewed verified by ORBi

COUCKE, P., WITHOFS, N., JANSEN, N., JANVARY, Z. L., & HUSTINX, R. (2010). Vers une radiothérapie chirurgicale :nécessité d’une radiothérapie guidée par l’imagerie. Revue Médicale de Liège, 65 (supp 1), 17-22.
Peer reviewed

Magis, D., Bruno, M.-A., Fumal, A., Gérardy, P.-Y., Hustinx, R., Laureys, S., & Schoenen, J. (2010). Central neuromodulation in cluster headache patients treated with occipital nerve stimulators: A PET study. Acta Neurologica Belgica, 110 (Suppl 1), 17.
Peer Reviewed verified by ORBi

Hustinx, R., & Lucignani, G. (2010). PET/CT in head and neck cancer: an update. European Journal of Nuclear Medicine and Molecular Imaging, 37 (3), 645-51. doi:10.1007/s00259-009-1365-9
Peer Reviewed verified by ORBi

Hustinx, R., & Beckers, C. (2010). Fluoride PET-CT. In S. Fanti, M. Farsad, ... L. Mansi (Eds.), PET-CT Beyond FDG (pp. 64-78). Berlin, Germany: Springer.

FOSSE, P., KAISER, M.-J., NAMUR, G., Malaise, M., & HUSTINX, R. (2010). Assessment of early therapeutic response in anti-TNFα refractory rheumatoid arthritis with FDG PET/CT. European Journal of Nuclear Medicine and Molecular Imaging, 37 (SUPPL), 211.
Peer Reviewed verified by ORBi

HUSTINX, R., & FOSSE, P. (2010). PET in Brain Tumors. In PET clinics 5 (pp. 185-197). Elsevier. doi:10.1016/j.cpet.2010.02.004
Peer reviewed

Bruno, M.-A., Vanhaudenhuyse, A., Schnakers, C., Boly, M., Gosseries, O., Demertzi, A., Majerus, S., Moonen, G., Hustinx, R., & Laureys, S. (2010). Visual fixation in the vegetative state: an observational case series PET study. BMC Neurology, 10, 35. doi:10.1186/1471-2377-10-35
Peer Reviewed verified by ORBi

Duysinx, B., Corhay, J.-L., Larock, M.-P., Withofs, N., Bury, T., Hustinx, R., & Louis, R. (2010). Contribution of positron emission tomography in pleural disease. Revue des Maladies Respiratoires, 27 (8), 47-53. doi:10.1016/j.rmr.2009.12.003
Peer Reviewed verified by ORBi

Nguyen Khac, M.-T., Hustinx, R., Deprez, M., Tshibanda, J., Lefebvre, P., Martin, D., & Robe, P. (21 March 2009). Tumor-like MRS and PET findings in a case of radiation-induced brain necrosis, away from any tumor: an intringuing case report [Paper presentation]. Réunion annuelle de la Société Belge de Neurochirurgie, LIEGE, Belgium.

Bonnet, C., Beguin, Y., De Prijck, B., Witvrouw, N., Hustinx, R., & Fillet, G. (2009). Les anticorps monoclonaux en hématologie en 2009. Revue Médicale de Liège, 64, 268-273.
Peer reviewed

Hustinx, R., & Louis, E. (2009). The Role of PET/CT in the Monitoring and Diagnosis of Pediatric Inflammatory Bowel Disease. PET Clinics, 3, 597-603. doi:10.1016/j.cpet.2009.04.003
Peer Reviewed verified by ORBi

Sakalihasan, N., Hustinx, R., Gomez, P., & Defraigne, J.-O. (2009). Functional imaging of abdominal aortic aneurysms : can it predict probability of rupture. In VASCULAR ANEURYSMS (pp. 91-102). Greece: Ed of University of Thessaly press.

RIBBENS, C., & HUSTINX, R. (2009). Nuclear (scintigraphic) methods and FDG-PET in rheumatoid arthritis and osteoarthritis. In M. A. Bruno (Ed.), Arthritis in Color. Advance Imaging of Arthritis. Philadelphia, Unknown/unspecified: Saunders, Elsevier. doi:10.1016/B978-1-4160-4722-3.00007-0
Editorial reviewed

Hustinx, R. (2009). Outils isotopiques : TEP et TEP/TDM. In J.-L. Dupas, E. Louis, ... P. Marteau, Maladies inflammatoires chroniques de l'intestin (pp. 137-148). Rueil-Malmaison Cedex, France: Wolters Kluwer France.

Schnakers, C., Perrin, F., Schabus, M., Hustinx, R., Majerus, S., Moonen, G., Boly, M., Vanhaudenhuyse, A., Bruno, M.-A., & Laureys, S. (2009). Detecting consciousness in a total Locked-in syndrome: an active event related paradigm. Neurocase: Case Studies in Neuropsychology, Neuropsychiatry and Behavioural Neurology, 25, 1-7. doi:10.1080/13554790902724904
Peer Reviewed verified by ORBi

Sakalihasan, N., Hustinx, R., Gomez, P., & Defraigne, J.-O. (2009). Evaluation of inflammatory cells in abdominal aortic aneurysmal wall by tomography emission positron. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 33/5, 279-284. doi:10.1016/j.mednuc.2009.03.002
Peer Reviewed verified by ORBi

Hustinx, R., & Louis, E. (2009). Outils isotopiques pour les MICI : PET et PET/CT. Côlon et Rectum, 3, 1-7. doi:10.1007/s11725-009-0147-7
Peer reviewed

Hustinx, R. (April 2008). PET/CT in gastrointestinal tumors : fast technological changes lead to improved patient management. PET Clinics, 3. doi:10.1016/j.cpet.2008.11.001
Peer Reviewed verified by ORBi

Hustinx, R., Witvrouw, N., & Tancredi, T. (April 2008). Liver metastases. PET Clinics, 3, 187-195. doi:10.1016/j.cpet.2008.09.004
Peer Reviewed verified by ORBi

LOVINFOSSE, P., BORN, J., MARTIN, D., LEMAIRE, C., AERTS, J., & HUSTINX, R. (2008). Evaluation of primary brain tumors with F-TYR and FDG PET : correlation with pathology and survival. Journal of Nuclear Medicine, 49 (SUPPL), 77.
Peer Reviewed verified by ORBi

Duysinx, B., Corhay, J.-L., Larock, M.-P., Nguyen Dang, D., Bury, T., Hustinx, R., & Louis, R. (2008). Prognostic value of metabolic imaging in non-small cell lung cancers with neoplasic pleural effusion. Nuclear Medicine Communications, 29 (11), 982-6. doi:10.1097/MNM.0b013e32830978c4
Peer Reviewed verified by ORBi

Schnakers, C., Hustinx, R., Vandewalle, G., Majerus, S., Moonen, G., Boly, M., Vanhaudenhuyse, A., Bruno, M.-A., & Laureys, S. (2008). Measuring the effect of amantadine in chronic anoxic minimally conscious state. Brain Injury.
Peer Reviewed verified by ORBi

Gosseries, O., Demertzi, A., Noirhomme, Q., Tshibanda, J., Boly, M., de Beeck, M. O., Hustinx, R., Maquet, P., Salmon, E., Moonen, G., Luxen, A., Laureys, S., & De Tiege, X. (2008). Que mesure la neuro-imagerie fonctionnelle: IRMf, TEP & MEG? Revue Médicale de Liège, 63 (5-6), 231-7.
Peer reviewed

Sakalihasan, N., Hustinx, R., Gomez, P., & Limet, R. (2008). Can Positron Emission Tomography (PET) predict the risk of rupture of abdominal aortic aneurysm(AAA)? In Controversies and updates in vascular surgery 2008 (pp. 15-22). Torino, Italy: Ed. Minerva Medica.

SAKALIHASAN, N., HUSTINX, R., GOMEZ, P., NCHIMI LONGANG, A., & LIMET, R. (2008). Can positron emission tomography (PET) predict the risk of rupture of abdominal aortic aneurysm (AAA) ? Controversies and updates in vascular surgery. In Can positron emission tomography (PET) predict the risk of rupture of abdominal aortic aneurysm (AAA) ? Controversies and updates in vascular surgery. Italy: Edizioni Minerva Medica.
Peer reviewed

Boly, M., Phillips, C., Tshibanda, L., Vanhaudenhuyse, A., Schabus, M., Dang Vu, T. T., Moonen, G., Hustinx, R., Maquet, P., & Laureys, S. (2008). Intrinsic brain activity in altered states of consciousness: how conscious is the default mode of brain function? Annals of the New York Academy of Sciences, 1129, 119-29. doi:10.1196/annals.1417.015
Peer Reviewed verified by ORBi

Hustinx, R., Jerusalem, G., & De Prijck, B. (2008). Tomographie à émission de positons et lymphomes. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 32, 449-455. doi:10.1016/j.mednuc.2008.06.002
Peer Reviewed verified by ORBi

Witvrouw, N., De Prijck, B., & Hustinx, R. (2008). Indications cliniques de la radiotherapie metabolique dans les lymphomes. Revue Médicale Suisse, 4 (168), 1818-22.
Peer Reviewed verified by ORBi

NAMUR, G., KAISER, M.-J., Deprez, M., MALAISE, M., & HUSTINX, R. (2008). Is FDG-PET/CT an early indicator of the clinical response to rituximab in rheumatoid arthritis ? Journal of Nuclear Medicine, 49 (SUPPL), 10.
Peer Reviewed verified by ORBi

Knuuti, J., & Hustinx, R. (2008). Highlights of the annual congress of the European Association of Nuclear Medicine, Copenhagen 2007. European Journal of Nuclear Medicine and Molecular Imaging, 35 (3), 655-72. doi:10.1007/s00259-007-0674-0
Peer Reviewed verified by ORBi

Sakalihasan, N., Hustinx, R., Gomez, P., & Limet, R. (2008). Functional imaging of abdominal aortic aneurysms. In Aortic Aneurysms, new insights of an old problem (pp. 395-406). Liège, Belgium: Editions de l’ULg.

WITHOFS, N., GRAYET, B., Tancredi, T., RORIVE, A., BECKERS, C., JERUSALEM, G., & HUSTINX, R. (2008). PET/CT for assessing bone involvement in prostate and breast cancer. Journal of Nuclear Medicine, 49 (SUPPL), 21.
Peer Reviewed verified by ORBi

Duysinx, B., Corhay, J.-L., Larock, M.-P., Withofs, N., Bury, T., Hustinx, R., & Louis, R. (2008). Apport de l'imagerie par tomographie a emission de positons dans la pathologie pleurale. Interet de la TEP en pathologie pleurale. Revue des Maladies Respiratoires, 25 (2), 129-38. doi:10.1016/S0761-8425(08)71511-0
Peer Reviewed verified by ORBi

Coucke, P., Barthelemy, N., Hustinx, R., & Fillet, G. (2008). Risk adaptive treatment in Hodgkin's lympoma: reduction of radiation dose and irradiated volume. Belgian Journal of Medical Oncology, 2 (2), 85-97.
Peer Reviewed verified by ORBi

Schnakers, C., Hustinx, R., Vandewalle, G., Majerus, S., Moonen, G., Boly, M., Vanhaudenhuyse, A., & Laureys, S. (2008). Measuring the effect of amantadine in chronic anoxic minimally conscious state. Journal of Neurology, Neurosurgery and Psychiatry, 79 (2), 225-7. doi:10.1136/jnnp.2007.124099
Peer Reviewed verified by ORBi

Sanjurjo, S., Hamida, W., Letesson, G., Hustinx, R., Gillet, P., & Andrianne, R. (2008). Repérage scintigraphique préopératoire d'une métastase costale unique d'un adénocarcinome prostatique opéré. Progrès en Urologie, 18 (6), 402-5. doi:10.1016/j.purol.2008.03.006
Peer Reviewed verified by ORBi

Louis, E., Ancion, G., Colard, A., Spote, V., Belaiche, J., & Hustinx, R. (July 2007). Noninvasive assessment of Crohn's disease intestinal lesions with F-18-FDG PET/CT. Journal of Nuclear Medicine, 48 (7), 1053-1059. doi:10.2967/jnumed.107.040436
Peer Reviewed verified by ORBi

WITHOFS, N., SALMON, E., LAUREYS, S., DESFONTAINES, P., MOONEN, G., & HUSTINX, R. (2007). Voxel-based analysis of posterior cingulated cortex metabolism in Alzheimer’s disease : effect of dementia severity and age. In PROCEEDINGS OF XIIIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE.
Peer reviewed

RUTTEN, I., CABAY, J.-E., WITHOFS, N., LEMAIRE, C., AERTS, J., BAART, V., & HUSTINX, R. (2007). PET/CT imaging of skull base meningiomas using 1-18F-fluoro-L-tyrosine; initial report. In PROCEEDINGS OF XIIIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE.
Peer reviewed

Rutten, I., Cabay, J.-E., Withofs, N., Lemaire, C., Aerts, J., Baart, V., & Hustinx, R. (May 2007). PET/CT of skull base meningiomas using 2-F-18-fluoro-L-tyrosine: Initial report. Journal of Nuclear Medicine, 48 (5), 720-725. doi:10.2967/jnumed.106.038216
Peer Reviewed verified by ORBi

MEDART, L., WITHOFS, N., HUSTINX, R., & DONDELINGER, R. (2007). Another etiology for inflammatory syndrome of unknown origin. In PROCEEDINGS OF XIIIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE.
Peer reviewed

MEDART, L., WITHOFS, N., HUSTINX, R., & DONDELINGER, R. (2007). Gossypiboma at PET-CT. In PROCEEDINGS OF XIIIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE.
Peer reviewed

Withofs, N., Salmon, E., Hallet, C., Desfontaines, P., Laureys, S., Moonen, G., & Hustinx, R. (May 2007). Effect of dementia severity and age on posterior cingulate cortex metabolism in Alzheimer's disease. Journal of Neurology, 254 (Suppl. 3), 146.
Peer Reviewed verified by ORBi

NAMUR, G., VAN DAMME, H., BECKERS, C., MEDART, M., WITHOFS, N., & HUSTINX, R. (2007). FDG PET/CT for diagnostic arterial prosthetic graft infection : preliminary report. In PROCEEDINGS OF XIIIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE.
Peer reviewed

HUSTINX, R., SPOTE, V., ANCION, G., COLLARD, A., BELAICHE, J., & LOUIS, E. (2007). Assessment of Crohn’s disease intestinal lesions with FDG PET/CT : A prospective correlation with endoscopy. Journal of Nuclear Medicine, 48 (SUPPL), 66.
Peer Reviewed verified by ORBi

Depas, G., Decortis, T., Francotte, N., Bricteux, G., & Hustinx, R. (2007). F-18 FDG PET in infectious diseases in children. Clinical Nuclear Medicine, 32 (8), 593-8. doi:10.1097/RLU.0b013e3180a1abe8
Peer Reviewed verified by ORBi

Rutten, I., Cabay, J.-E., Withofs, N., Lemaire, C., Aerts, J., Baart, V., & HUSTINX, R. (2007). PET/CT imaging of skull base meningiomas using 2-18F-fluoro-L-tyrosine : Initial report. Journal of Nuclear Medicine, 48 (SUPPL), 11.
Peer Reviewed verified by ORBi

Hustinx, R., & Detry, O. (2007). Hepatobiliary disease : primary and metastatic liver tumours. In G. J. Cook, M. M. Maisey, K. Britton, ... V. Chengazi (Eds.), Clinical Nuclear Medicine (Fourth Edition, pp. 661-672). New York, United States: Edward Arnold Ltd.

Quatresooz, P., Hustinx, R., Franchimont, C., & Pierard, G. (2007). Le mélanome cutané dans une perspective liégeoise. Actualisation de son épidémiologie et avancées diagnostiques. Revue Médicale de Liège, 62 (Supplément), 52-S55.
Peer reviewed

DUYSINX, B., LAROCK, M.-P., CORHAY, J.-L., NGUYEN DANG, D., LOUIS, R., & HUSTINX, R. (2007). Prognostic value of metabolic imaging in locally advanced non small cell lung cancers. Journal of Nuclear Medicine, 48 (SUPPL), 358.
Peer Reviewed verified by ORBi

WITHOFS, N., SALMON, E., LAUREYS, S., DESFONTAINES, P., & HUSTINX, R. (2007). Voxel-based analysis of dementia severity versus age on cerebral metabolic dysfunction in Alzheimer’s disease. Journal of Nuclear Medicine, 48 (SUPPL), 172.
Peer Reviewed verified by ORBi

Jerusalem, G., Withofs, N., Rorive, A., & Hustinx, R. (2007). Tomographie a emission de positons: un premier bilan. Revue du Praticien, 57 (17), 1864-70.
Peer reviewed

DUYSINX, B., Larock, M.-P., Nguyen, D., Corhay, J.-L., Bury, T., Hustinx, R., & Louis, R. (December 2006). 18f-Fdg Pet Imaging in Assessing Exudative Pleural Effusions. Nuclear Medicine Communications, 27 (12), 971-6. doi:10.1097/01.mnm.0000243366.96012.c0
Peer Reviewed verified by ORBi

Delcroix, G., Vanstraelen, G., Hustinx, R., Delvenne, P., Hayette, M.-P., Massion, P., & Canivet, J.-L. (October 2006). Pericardite aspergillaire avec tamponnade cardiaque et syndrome hemophagocytaire: un cas non classique d'immunodeficience. Revue Médicale de Liège, 61 (10), 713-8.
Peer reviewed

Seret, A., & Hustinx, R. (August 2006). Clinical applications of pinhole single photon emission tomography. Current Medical Imaging Reviews, 2 (3), 347-352. doi:10.2174/157340506777934570
Peer Reviewed verified by ORBi

Jerusalem, G., Silvestre, R., Beguin, Y., Hustinx, R., Fassotte, M.-F., & Fillet, G. (20 June 2006). FDG-PET for the routine follow-up in NHL: First prospective evaluation. Journal of Clinical Oncology, 24 (18, Part 1 Suppl. S), 439.
Peer Reviewed verified by ORBi

Beckers, C., Jeukens, X., Ribbens, C., Andre, B., Marcelis, S., Leclercq, P., Kaiser, M.-J., Willems, J., Hustinx, R., & Malaise, M. (March 2006). F-18-FDG PET imaging of rheumatoid knee synovitis correlates with dynamic magnetic resonance and sonographic assessments as well as with the serum level of metalloproteinase-3. European Journal of Nuclear Medicine and Molecular Imaging, 33 (3), 275-280. doi:10.1007/s00259-005-1952-3
Peer Reviewed verified by ORBi

Zhuang, H., Hustinx, R., & Alavi, A. (2006). Effect of diazepam on the efficacy of dual-phase FDG PET imaging. European Journal of Nuclear Medicine and Molecular Imaging, 33 (2), 228-9; author reply 230. doi:10.1007/s00259-005-1957-y
Peer Reviewed verified by ORBi

Heymans, O., Fallais, C., & Hustinx, R. (2006). Intratissular Lymphaticovenous Anastomoses Demonstrated by Perioperative Intramuscular Injection of 99mtc-Colloids. Lymphatic Research and Biology, 4 (1, Spring), 29-33. doi:10.1089/lrb.2006.4.29
Peer Reviewed verified by ORBi

Jerusalem, G., Rorive, A., Ancion, G., Hustinx, R., & Fillet, G. (2006). Diagnostic and therapeutic management of carcinoma of unknown primary: radio-imaging investigations. Annals of Oncology, 17 Suppl 10, 168-76. doi:10.1093/annonc/mdl255
Peer Reviewed verified by ORBi

Rigo, P., Hustinx, R., & Bury, T. (2006). PET and PET/CT Imaging in Lung Cancer. In P. Valk, D. Delbeke, D. Bailey, D. Townsend, ... M. Maisey (Eds.), Positron Emission Tomography - Clnical practice (pp. 89-106). Springer.
Peer reviewed

Couturier, O., Jerusalem, G., N'Guyen, J.-M., & Hustinx, R. (2006). Sequential positron emission tomography using [18F]fluorodeoxyglucose for monitoring response to chemotherapy in metastatic breast cancer. Clinical Cancer Research, 12 (21), 6437-43. doi:10.1158/1078-0432.CCR-06-0383
Peer Reviewed verified by ORBi

Belhocine, T., Pierard, G., Frühling, J., Letesson, G., Bolle, S., Hustinx, R., Dargent, J.-L., Flamen, P., & Rigo, P. (2006). Clinical added-value of 18FDG PET in neuroendocrine-merkel cell carcinoma. Oncology Reports, 16 (2), 347-352. doi:10.3892/or.16.2.347
Peer Reviewed verified by ORBi

Laret, V., Sion, C., Bataille, C., Hustinx, R., & Reginster, M. (2006). Le cas clinique du mois. Colite a clostridium difficile. Revue Médicale de Liège, 61 (11), 750-2.
Peer reviewed

Hustinx, R., & Malaise, M. (2006). PET imaging of arthritis. PET Clinics, 1, 131-139. doi:10.1016/j.cpet.2006.02.003
Peer Reviewed verified by ORBi

Jerusalem, G., & Hustinx, R. (2006). The lymphomas. Nuclear Medicine. In G. P. Canellos, A. T. Lister, ... B. Young, The lymphomas (pp. 189-202). Philadelphia, United States: Saunders.

Jerusalem, G., Hustinx, R., & Rigo, P. (2006). PET and PET/CT imaging in lymphomas. In P. E. Valk, D. Delbeke, D. L. Bailey, D. W. Townsend, ... M. N. Maisey, Positron emission tomography (pp. 125-145). Londres, United Kingdom: Springer.

Rigo, P., Hustinx, R., & Bury, T. (2006). PET imaging in lung cancer. In P. E. Valk, D. Delbeke, D. L. Bailey, D. W. Townsend, ... M. M. Maisey (Eds.), Positron emission tomography (pp. 89-106). Londres, United Kingdom: Springer.

Couturier, O., Léost, F., Campone, M., Carlier, T., Chatal, J.-F., & Hustinx, R. (September 2005). Is 3 '-deoxy-3 '-[F-18] fluorothymidine ([F-18]-FLT) the next tracer for routine clinical PET after R [F-18]-FDG? Bulletin du Cancer, 92 (9), 789-798.
Peer Reviewed verified by ORBi

Defawe, O. D., Hustinx, R., Defraigne, J.-O., Limet, R., & Sakalihasan, N. (May 2005). Distribution of F-18 fluorodeoxyglucose (F-18 FDG) in abdominal aortic aneurysm: High accumulation in macrophages seen on PET Imaging and immunohistology. Clinical Nuclear Medicine, 30 (5), 340-341. doi:10.1097/01.rlu.0000159681.24833.95
Peer Reviewed verified by ORBi

Ancion, G., Foidart-Willems, J., Willems, V., & Hustinx, R. (2005). L'image du mois. Mise en evidence d'une metastase intracanalaire rachidienne d'un carcinome pulmonaire par TEP/TDM. Revue Médicale de Liège, 60 (7-8, Jul-Aug), 637-8.
Peer reviewed

BECKERS, C., BERNARD, C., KAISER, M.-J., RIBBENS, C., MALAISE, M., & HUSTINX, R. (2005). Time-course study of (F-18)-FDG uptake in psoriatic synovitis. Journal of Nuclear Medicine, 46 (SUPPL), 183.
Peer Reviewed verified by ORBi

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2005). Whole-Body Positron Emission Tomography using 18F-Fluorodeoxyglucose for Staging Response Assessment in Hodgkin's Disease. In B. C. Heinz (Ed.), Trends in Hodgkin's Disease Research (pp. 169-188). New York, United States: Nova Science Publishers.

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2005). Positron emission tomography imaging for lymphoma. Current Opinion in Oncology, 17 (5), 441-5. doi:10.1097/01.cco.0000174041.29557.5c
Peer Reviewed verified by ORBi

LETESSON, G., FOIDART-WILLEMS, J., & HUSTINX, R. (2005). FDG-PET imaging for diagnosing bone infection. Journal of Nuclear Medicine, 46 (SUPPL), 323.
Peer Reviewed verified by ORBi

Hustinx, R., Pourdehnad, M., Kaschten, B., & Alavi, A. (January 2005). PET imaging for differentiating recurrent brain tumor from radiation necrosis. Radiologic Clinics of North America, 43 (1), 35-47. doi:10.1016/j.rcl.2004.09.009
Peer Reviewed verified by ORBi

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2005). Evaluation of therapy for lymphoma. Seminars in Nuclear Medicine, 35 (3), 186-96. doi:10.1053/j.semnuclmed.2005.02.004
Peer Reviewed verified by ORBi

Couturier, O., Leost, F., Campone, M., Carlier, T., Chatal, J.-F., & Hustinx, R. (2005). La 3'-deoxy-3'-[18F] fluorothymidine ([18F]-FLT) est-elle le prochain traceur utilise en routine pour la TEP apres le [18F]-FDG? Bulletin du Cancer, 92 (9), 789-98.
Peer Reviewed verified by ORBi

LAROCK, M.-P., DUYSINX, B., NGUYEN, D., CORHAY, J.-L., BURY, T., LOUIS, R., & HUSTINX, R. (2005). FDG-PET imaging for assessing pleural malignancy : a semi-quantitative analysis. Journal of Nuclear Medicine, 46 (SUPPL), 426.
Peer Reviewed verified by ORBi

HEYMANS, FALLAIS, C., & HUSTINX, R. (2005). Intratissular lymphaticovenous anastomoses demonstrated by preoperative injection of 99mTc colloids. Journal of Nuclear Medicine, 46 (SUPPL), 326.
Peer Reviewed verified by ORBi

Depas, G., De Barsy, C., Jerusalem, G., Hoyoux, C., DRESSE, M.-F., Fassotte, M.-F., Paquet, N., Willems, J., Rigo, P., & Hustinx, R. (January 2005). F-18-FDG PET in children with lymphomas. European Journal of Nuclear Medicine and Molecular Imaging, 32 (1), 31-38. doi:10.1007/s00259-004-1604-z
Peer Reviewed verified by ORBi

Hustinx, R. (November 2004). PET imaging in assessing gastrointestinal tumors [letter to the editor]. Radiologic Clinics of North America, 42 (6), 1123. doi:10.1016/j.rcl.2004.08.003
Peer Reviewed verified by ORBi

Couturier, O., Chatal, J.-F., & Hustinx, R. (September 2004). Fluorinated analogs of nucleosides and fluorinated tracers of gene expression for positron emission tomography. Bulletin du Cancer, 91 (9), 695-703.
Peer Reviewed verified by ORBi

Couturier, O., Luxen, A., Chatal, J.-F., Vuillez, J.-P., Rigo, P., & Hustinx, R. (August 2004). Fluorinated tracers for imaging cancer with positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging, 31 (8), 1182-1206. doi:10.1007/s00259-004-1607-9
Peer Reviewed verified by ORBi

Beckers, C., Ribbens, C., Andre, B., Marcelis, S., Kaye, O., Mathy, L., KAISER, M.-J., Hustinx, R., Willems, J., & Malaise, M. (June 2004). Assessment of disease activity in rheumatoid arthritis with 18F-FDG PET. Journal of Nuclear Medicine, 45 (6), 956-964.
Peer Reviewed verified by ORBi

Sakalihasan, N., Hustinx, R., & Limet, R. (June 2004). Contribution of Pet Scanning to the Evaluation of Abdominal Aortic Aneurysm. Seminars in Vascular Surgery, 17 (2), 144-53. doi:10.1053/j.semvascsurg.2004.03.002
Peer Reviewed verified by ORBi

Paquet, N., Albert, A., Willems, J., & Hustinx, R. (May 2004). Within-patient variability of F-18-FDG: Standardized uptake values in normal tissues. Journal of Nuclear Medicine, 45 (5), 784-788.
Peer Reviewed verified by ORBi

Kaschten, B., Lemaire, C., Luxen, A., Stevenaert, A., & HUSTINX, R. (2004). 18F-tyrosine PET in Neurooncology : an alternative to 11C-methionine. Journal of Nuclear Medicine, 45 (SUPPL), 264.
Peer Reviewed verified by ORBi

Rigo, P., Hustinx, R., & Bury, T. (2004). PET in lung cancer. In D. L. Bailey, D. W. Townsend, P. E. Valk, ... M. N. Maisey, Positron emission tomography. Principles and practice (pp. 517-534). Springer.

Couturier, O., Hustinx, R., & Chatal, J.-F. (2004). New strategies and new impact of cancer imaging. In J. SERVIER (Ed.), Cancer : recent evidence, innovative strategies, future promises (pp. 98-104). Paris, France: Elsevier.

Couturier, O., Bodet-Milin, C., Cherel, M., & Hustinx, R. (2004). Traceurs fluorés de la prolifération des cancers en tomographie par émission de positons. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 28 (8), 371-376.
Peer Reviewed verified by ORBi

Jerusalem, G., & Hustinx, R. (15 October 2003). Tomographie a emission de positons: une revolution en cancerologie? Revue du Praticien, 53 (15), 1629-30.
Peer reviewed

Alberini, J. L., Belhocine, T., Hustinx, R., Daenen, F., & Rigo, P. (October 2003). Whole-body positron emission tomography using fluorodeoxyglucose in patients with metastases of unknown primary tumours (CUP syndrome). Nuclear Medicine Communications, 24 (10), 1081-1086. doi:10.1097/00006231-200310000-00008
Peer Reviewed verified by ORBi

Belhocine, T., Blockmans, D., Hustinx, R., Vandevivere, J., & Mortelmans, L. (September 2003). Imaging of large vessel vasculitis with (18)FDG PET: illusion or reality? A critical review of the literature data [letter to the editor]. European Journal of Nuclear Medicine and Molecular Imaging, 30 (9), 1305-1313. doi:10.1007/s00259-003-1209-y
Peer Reviewed verified by ORBi

Belhocine, T., Kridelka, F., Thille, A., De Barsy, C., Foidart-Willems, J., Hustinx, R., & Rigo, P. (June 2003). Staging of primary cervical cancers: the role of nuclear medicine [letter to the editor]. Critical Reviews in Oncology/Hematology, 46 (3), 275-284. doi:10.1016/S1040-8428(03)00027-1
Peer Reviewed verified by ORBi

Bénard, F., Romsa, J., & Hustinx, R. (April 2003). Imaging gliomas with positron emission tomography and single-photon emission computed tomography [letter to the editor]. Seminars in Nuclear Medicine, 33 (2), 148-162. doi:10.1053/snuc.2003.127304
Peer Reviewed verified by ORBi

Hustinx, R., Lemaire, C., Jerusalem, G., Moreau, P., Cataldo, D., Duysinx, B., Aerts, J., Fassotte, M.-F., Foidart, J., & Luxen, A. (April 2003). Whole-body tumor imaging using PET and 2-18F-fluoro-l-tyrosine: Preliminary evaluation and comparison with 18F-FDG. Journal of Nuclear Medicine, 44 (4), 533-539.
Peer Reviewed verified by ORBi

Hustinx, R., Sautois, B., Jerusalem, G., & Foidart, J. (2003). Radiothérapie métabolique des douleurs osseuses métastatiques. Médecine et Hygiène, 61, 1560-1564.
Peer Reviewed verified by ORBi

PAQUET, N., HUSTINX, R., & FOIDART-WILLEMS, J. (2003). Intra-patient variability of SUV in normal tissues. European Journal of Nuclear Medicine and Molecular Imaging, 30 (SUPPL 2), 327.
Peer Reviewed verified by ORBi

Paquet, P., Hustinx, R., Rigo, P., & Pierard, G. (2003). Malignant melanoma. In P. Oehr, H. J. Biersack, ... E. R. Coleman (Eds.), PET and PET-CT in Oncology (pp. 259-265). Heidelberg, Germany: Srpinger.

DE BARSY, DEPAS, G., DRESSE, M.-F., HOYOUX, C., SCHMITZ, V., JERUSALEM, G., FASSOTTE, M.-F., FOIDART-WILLEMS, J., & HUSTINX, R. (2003). Whole-body FDG PET in the follow-up of pediatric patients with lymphoma. Journal of Nuclear Medicine, 44, 346.
Peer Reviewed verified by ORBi

Hustinx, R. (2003). Tomographie à émission de positons : vers une approche plus spécifique des pathologies oncologiques [Post doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/11898

BELHOCINE, T., THILLE, A., DE BARSY, C., KRIDELKA, F., HUSTINX, R., & FOIDART-WILLEMS, J. (2003). Added value of whole body 18FDG PET imaging in monitoring uterine cancers. European Journal of Nuclear Medicine and Molecular Imaging, 30 (SUPPL 2), 269.
Peer Reviewed verified by ORBi

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Belhocine, T., Hustinx, R., Rigo, P., & Fillet, G. (2003). Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease. Annals of Oncology, 14 (1), 123-30. doi:10.1093/annonc/mdg011
Peer Reviewed verified by ORBi

Hustinx, R., & Alavi, A. (2003). Tumor imaging. In C. S. Redvanly & M. J. Welch (Ed.), Handbook of Radiopharmaceuticals. Radiochemistry and Applications (pp. 629-642). Chichester, United Kingdom: John Wiley & Sons.

Hustinx, R., & Paulus, P. (2003). Radiothérapie métabolique des douleurs osseuses d'origine métastatique : nouveaux traitements, nouvelles pratiques. Annalen van de Belgische Vereniging voor Stralingsbescherming, 28, 9-20.

Jerusalem, G., Hustinx, R., Beguin, Y., Depas, G., Fassotte, M.-F., De Barsy, C., Foidart, J., & Fillet, G. (2003). Les lymphomes. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 27 (8), 401-410.
Peer Reviewed verified by ORBi

PAQUET, N., LEFEBVRE, B., HUSTINX, R., FORTIN, A., & CAMIRE, M. (2003). Value of 18FDG gamma camera coincidence imaging in the follow-up of head and neck squamous cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging, 30 (SUPPL 2), 278.
Peer Reviewed verified by ORBi

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2003). PET scan imaging in oncology. European Journal of Cancer, 39 (11), 1525-34. doi:10.1016/S0959-8049(03)00374-5
Peer Reviewed verified by ORBi

DE BARSY, DEPAS, G., DRESSE, M.-F., HOYOUX, C., SCHMITZ, V., JERUSALEM, G., FASSOTTE, M.-F., FOIDART-WILLEMS, J., & HUSTINX, R. (2003). Whole-body FDG PET imaging as a method for staging and early assessment of treatment response in pediatric patients with lymphoma. Journal of Nuclear Medicine, 44, 183.
Peer Reviewed verified by ORBi

Belhocine, T., Steinmetz, N., Hustinx, R., Bartsch, P., Jerusalem, G., Seidel, L., Rigo, P., & Green, A. (September 2002). Increased uptake of the apoptosis-imaging agent (99m)Tc recombinant human annexin V in human tumors after one course of chemotherapy as a predictor of tumor response and patient prognosis. Clinical Cancer Research, 8 (9), 2766-2774.
Peer Reviewed verified by ORBi

Belhocine, T., De Barsy, C., Hustinx, R., & Willems-Foidart, J. (September 2002). Usefulness of F-18-FDG PET in the post-therapy surveillance of endometrial carcinoma. European Journal of Nuclear Medicine and Molecular Imaging, 29 (9), 1132-1139. doi:10.1007/s00259-002-0878-2
Peer Reviewed verified by ORBi

Belhocine, T., Willems, J., Rigo, P., Najjar, F., Thiry, A., Quatresooz, P., & Hustinx, R. (August 2002). Fluorodeoxyglucose positron emission tomography and somatostatin receptor scintigraphy for diagnosing and staging carcinoid tumours: correlations with the pathological indexes p53 and Ki-67. Nuclear Medicine Communications, 23 (8), 727-734. doi:10.1097/00006231-200208000-00005
Peer Reviewed verified by ORBi

DE BARSY, C., DAENEN, F., BENARD, F., & HUSTINX, R. (2002). Is FDG bowel uptake modified by oral spasmolytic premedication ? Journal of Nuclear Medicine, 43, 203.
Peer Reviewed verified by ORBi

Malaise, M., Kaye, O., Radermecker, M., Duysinx, B., Hustinx, R., Hermans, G., & de Leval, L. (2002). Une dorsalgie malheureusement tenace. Revue Médicale de Liège, 57 (5), 270-273.
Peer reviewed

Hustinx, R., Bénard, F., & Alavi, A. (January 2002). Whole-body FDG-PET imaging in the management of patients with cancer [letter to the editor]. Seminars in Nuclear Medicine, 32 (1), 35-46. doi:10.1053/snuc.2002.29272
Peer Reviewed verified by ORBi

BECKERS, C., RIBBENS, C., ANDRE, B., MARCELLIS, M., KAYE, O., RIGO, P., HUSTINX, R., FOIDART-WILLEMS, J., & MALAISE, M. (2002). FDG-PET imaging for monitoring rheumatoid arthritis treated by infliximab injections. Journal of Nuclear Medicine, 43, 38.
Peer Reviewed verified by ORBi

HUSTINX, R., Lemaire, C., JERUSALEM, G., MOREAU, P., Cataldo, D., DUYSINX, B., Aerts, J., & Luxen, A. (2002). 18F-fluoro-L-tyrosine : a potential tracer for whole-body tumor imaging with PET. Journal of Nuclear Medicine, 43, 77.
Peer Reviewed verified by ORBi

Warland, V., Jerusalem, G., Hustinx, R., Beguin, Y., Silvestre, R. M., Fassotte, M.-F., Foidart, J., & Fillet, G. (2002). Comment etablir le bilan de fin de traitement des patients atteints de lymphomes non-hodgkiniens (LNH) de malignite intermediaire ou elevee? Revue Médicale de Liège, 57 (12), 779-84.
Peer reviewed

Belhocine, T., Kaye, O., Delanaye, P., Corman, V., Baghaie, M., Deprez, M., Daenen, F., De Barsy, C., Beckers, C., Gomez, P., Hustinx, R., Foidart-Willems, J., Demonty, J., Malaise, M., & Rigo, P. (2002). Maladie de Horton et atteintes arterielles extratemporales: utilite de la tomographie par emission de positons au 18FDG. A propos de trois observations et d'une revue de la litterature. Revue de Médecine Interne, 23 (7), 584-91. doi:10.1016/S0248-8663(02)00620-3
Peer Reviewed verified by ORBi

BECKERS, C., RIBBENS, C., ANDRE, B., MARCELLIS, M., KAYE, O., RIGO, P., HUSTINX, R., FOIDART-WILLEMS, J., & MALAISE, M. (2002). Characterization of inflamed joints in rheumatoid arthritis patients using FDG-PET: correlation with clinical and ultrasonographical assessment. Journal of Nuclear Medicine, 43, 38.
Peer Reviewed verified by ORBi

Jerusalem, G., Hustinx, R., Beguin, Y., & Fillet, G. (2002). The value of positron emission tomography (PET) imaging in disease staging and therapy assessment. Annals of Oncology, 13 Suppl 4, 227-34. doi:10.1093/annonc/mdf664
Peer Reviewed verified by ORBi

Najjar, F., Hustinx, R., Jerusalem, G., Fillet, G., & Rigo, P. (August 2001). Positron Emission Tomography (PET) for Staging Low-Grade Non-Hodgkin's Lymphomas (NHL). Cancer Biotherapy and Radiopharmaceuticals, 16 (4), 297-304. doi:10.1089/108497801753131372
Peer Reviewed verified by ORBi

Albérini, J.-L., Belhocine, T., Daenen, F., Hustinx, R., & Rigo, P. (2001). Apport de la tomographie par émission de positons pour la détection des tumeurs primitives lors de la découverte de métastases. Bulletin du Cancer, 88 (5), 518-519.
Peer Reviewed verified by ORBi

BELHOCINE, T., HUSTINX, R., GIELEN, J.-L., DAENEN, F., DE BARSY, C., de LA BRASSINNE, M., PIERARD, G., LAHAYE, T., & RIGO, P. (2001). Usefulness of sentinel node biopsy and FDG PET imaging in loco-regional lymph node staging of malignant melanoma. Journal of Nuclear Medicine, 42, 298.
Peer Reviewed verified by ORBi

BELHOCINE, T., HUSTINX, R., KRIDELKA, F., THILLE, A., DAENEN, F., DE BARSY, C., & RIGO, P. (2001). Usefulness of FDG-PET imaging in the management of cervical carcinoma. Journal of Nuclear Medicine, 42, 286.
Peer Reviewed verified by ORBi

BECKERS, C., HUSTINX, R., FOIDART-WILLEMS, J., RIGO, P., & MALAISE, M. (2001). Glucose metabolism in rheumatoid arthritis knee joints before and after anti-TNF-apha blockade : evaluation by PET with 18-FDG. IN PROCEEDINGS ANNUAL AMI MEETING 2001, P56.
Peer reviewed

Jerusalem, G., Beguin, Y., Najjar, F., Hustinx, R., Fassotte, M.-F., Rigo, P., & Fillet, G. (2001). Positron emission tomography (PET) with 18F-fluorodeoxyglucose (18F-FDG) for the staging of low-grade non-Hodgkin's lymphoma (NHL). Annals of Oncology, 12 (6), 825-30. doi:10.1023/A:1011169332265
Peer Reviewed verified by ORBi

Shiue, G. G., Shiue, C.-Y., Lee, R. L., MacDonald, D., Hustinx, R., Eck, S. L., & Alavi, A. (2001). A simplified one-pot synthesis of 9-[(3-[18F]fluoro-1-hydroxy-2-propoxy)methyl]guanine([18F]FHPG) and 9-(4-[18F]fluoro-3-hydroxymethylbutyl)guanine ([18F]FHBG) for gene therapy. Nuclear Medicine and Biology, 28 (7), 875-83. doi:10.1016/S0969-8051(01)00253-0
Peer Reviewed verified by ORBi

Hustinx, R., Shiue, C. Y., Alavi, A., McDonald, D., Shiue, G. G., Zhuang, H., Lanuti, M., Lambright, E., Karp, J. S., & Eck, S. L. (January 2001). Imaging in Vivo Herpes Simplex Virus Thymidine Kinase Gene Transfer to Tumour-Bearing Rodents Using Positron Emission Tomography And. European Journal of Nuclear Medicine, 28 (1), 5-12. doi:10.1007/s002590000396
Peer Reviewed verified by ORBi

Jerusalem, G., Belhocine, T., Silvestre, R.-M., Sautois, B., Hustinx, R., Beguin, Y., Fillet, G., & Rigo, P. (2001). Place de la tomographie d'émission de positons dans le suivi thérapeutique du cancer du sein. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 25 (6), 341-346.
Peer Reviewed verified by ORBi

Daenen, F., Hustinx, R., Belhocine, T., Focan, C., Honore, P., & Rigo, P. (February 2000). Tomographie a emission de positons au 18FDG et adenocarcinome pancreatique. Revue Médicale de Liège, 55 (2), 89-94.
Peer reviewed

JERUSALEM, G., BEGUIN, Y., FASSOTTE, M.-F., BELHOCINE, T., HUSTINX, R., RIGO, P., & FILLET, G. (2000). Early detection of relapse by whole-body positron emission tomography (PET) using 18F-fluorodeoxyglucose (18F-FDG) in the follow-up of patients with Hodgkin’s disease (HD). PROCEEDINGS OF AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING 2000, 19, 10.
Peer reviewed

NAJJAR, F., HUSTINX, R., JERUSALEM, G., FILLET, G., & RIGO, P. (2000). Whole-body 18FDG-PET for staging low grade non Hodgkin’s lymphoma. European Journal of Nuclear Medicine, 27, 1159.
Peer Reviewed verified by ORBi

Bhatnagar, A., Hustinx, R., & Alavi, A. (2000). Nuclear imaging methods for non-invasive drug monitoring. Advanced Drug Delivery Reviews, 41 (1), 41-54. doi:10.1016/S0169-409X(99)00055-1
Peer Reviewed verified by ORBi

BELHOCINE, T., HUSTINX, R., JERUSALEM, G., FASSOTTE, M.-F., DUYSINX, B., QUADEN, C., & RIGO, P. (2000). 99mTc rh-Annexin V (ApomateTM) as a marker of apoptosis resulting from chemotherapy : preliminary results. Journal of Nuclear Medicine, 41 (SUPPL), 263.
Peer Reviewed verified by ORBi

SMITH, R., MATTHIES, A., HUSTINX, R., & ALAVI, A. (2000). The value and limitations of SUV measurements and method to enhance their utility. European Journal of Nuclear Medicine, 27, 1002.
Peer Reviewed verified by ORBi

Paquet, P., Henry, F., Belhocine, T., Hustinx, R., Najjar, F., Pierard-Franchimont, C., Pierard, G., & Rigo, P. (2000). An Appraisal of 18-Fluorodeoxyglucose Positron Emission Tomography for Melanoma Staging. Dermatology, 200 (2), 167-9. doi:10.1159/000018357
Peer Reviewed verified by ORBi

Rigo, P., Belhocine, T., Hustinx, R., & Foidart, J. (2000). TEP et tumeurs endocrines. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 24 (5), 275-282.
Peer Reviewed verified by ORBi

HUSTINX, R. (2000). Intérêt de la tomographie à émission de positons au FDG dans les néoplasies colorectales et hépatiques: aspects cliniques et méthodologiques [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/167926

Evans, S. M., Kachur, A. V., Shiue, C. Y., Hustinx, R., Jenkins, W. T., Shive, G. G., Karp, J. S., Alavi, A., Lord, E. M., Dolbier, W. R. J., & Koch, C. J. (2000). Noninvasive detection of tumor hypoxia using the 2-nitroimidazole [18F]EF1. Journal of Nuclear Medicine, 41 (2), 327-36.
Peer Reviewed verified by ORBi

BENARD, F., SMITH, R., ALAVI, A., VERREAULT, J., HUSTINX, R., & MATTHIES, A. (2000). Relationship between camera physical characteristics and clinical performance of patient studies: an evaluation of two dedicated PET systems. Journal of Nuclear Medicine, 41 (SUPPL), 180.
Peer Reviewed verified by ORBi

SMITH, R., BENARD, F., HUSTINX, R., & ALAVI, A. (2000). Measured attenuation correction in whole-body PET : essential and simple. European Journal of Nuclear Medicine, 27, 1000.
Peer Reviewed verified by ORBi

HUSTINX, R., SHIUE, C., ZHUANG, H., MCDONALD, D., LANUTI, M., LAMBRIGHT, E., SHIUE, G., SMITH, G., KARP, J., LU, P., ECK, S., & ALAVI, A. (2000). Imaging in vivo herpes simplex virus thymidine kinase gene transfer and expression in tumors using positron emission tomography. Journal of Nuclear Medicine, 41 (SUPPL), 264.
Peer Reviewed verified by ORBi

Belhocine, T., Hustinx, R., Devillers, C., Daenen, F., Beckers, C., Paulus, D., & Rigo, P. (2000). PET for carcinomas of the genitourinary system. In I. Khakhali, J. Laublant, ... S. J. Goldsmith, NUCLEAR ONCOLOGY : DIAGNOSIS AND THERAPY (pp. 403-416). Londres, United Kingdom: Lippincott Williams and Wilkins.

Hustinx, R., Dolin, R. J., Benard, F., Bhatnagar, A., Chakraborty, D., Smith, R. J., Jang, S., & Alavi, A. (2000). Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: a free-response ROC analysis. European Journal of Nuclear Medicine, 27 (9), 1365-71. doi:10.1007/s002590000287
Peer Reviewed verified by ORBi

Jerusalem, G., Beguin, Y., Fassotte, M.-F., Belhocine, T., Najjar, F., Hustinx, R., Rigo, P., & Fillet, G. (2000). Evaluation thérapeutique précoce par tomographie à émission de positons. Médecine et Hygiène, 58, 1629-1632.
Peer Reviewed verified by ORBi

Hustinx, R., Paulus, P., Daenen, F., Detroz, B., Honore, P., Comhair, N., & Rigo, P. (December 1999). Intérêt de la tomographie a émission de positons dans l'évaluation des tumeurs digestives. Revue Médicale de Liège, 54 (12), 925-30.
Peer reviewed

Hustinx, R., Paulus, P., Daenen, F., Detroz, B., Honore, P., Comhair, N., & Rigo, P. (March 1999). Interet clinique de la tomographie a emission de positons dans la detection et le bilan d'extension des recidives des cancers colorectaux. Gastroentérologie Clinique et Biologique, 23 (3), 323-9.
Peer Reviewed verified by ORBi

Rigo, P., Albérini, J.-L., Hustinx, R., Paulus, P., Baretto, A., & Daenen, F. (1999). Intérêt de la tomographie à émission de positons dans l'évaluation des tumeurs gastro-intestinales. Acta Endoscopica, 29 (2), 129-138.
Peer reviewed

HUSTINX, R., EVANS, S., KACHUR, C., SHIUE, C., JENKINS, W., SHIUE, G., KARP, J., LORD, E., DOLBIER, R., ALAVI, A., & KOCH, C. (1999). Non-invasive assessment of tumor hypoxia with the 2-nitroimidazole 18F-EF1 and PET. Journal of Nuclear Medicine, 40, 99.
Peer Reviewed verified by ORBi

SHIUE, C., SHIUE, G., HUSTINX, R., ALAVI, A., & ECK, S. (1999). An improved synthesis of 9-[(3)-[F-18]fluoro-1-hydroxy-2-propoxy)methyl]guanine ([F-18]FHPG). Journal of Nuclear Medicine, 40, 83.
Peer Reviewed verified by ORBi

DUARTE, P., HUSTINX, R., COUTURIER, O., SMITH, R., & ALAVI, A. (1999). Hottest pixel analysis: Useful value or statistical artifact ? Journal of Nuclear Medicine, 40, 292.
Peer Reviewed verified by ORBi

Hustinx, R., Smith, R. J., Benard, F., Rosenthal, D. I., Machtay, M., Farber, L. A., & Alavi, A. (1999). Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck. European Journal of Nuclear Medicine, 26 (10), 1345-8. doi:10.1007/s002590050593
Peer Reviewed verified by ORBi

HUSTINX, R., SMITH, R., ROSENTHAL, D., & ALAVI, A. (1999). Dual time-point FDG-PET imaging to distinguish tumor from normal and inflammatory sites in the head and neck. Journal of Nuclear Medicine, 40, 237.
Peer Reviewed verified by ORBi

Hustinx, R., Eck, S. L., & Alavi, A. (1999). Potential applications of PET imaging in developing novel cancer therapies. Journal of Nuclear Medicine, 40 (6), 995-1002.
Peer Reviewed verified by ORBi

Benard, F., Smith, R. J., Hustinx, R., Karp, J. S., & Alavi, A. (1999). Clinical evaluation of processing techniques for attenuation correction with 137Cs in whole-body PET imaging. Journal of Nuclear Medicine, 40 (8), 1257-63.
Peer Reviewed verified by ORBi

POURDEHNAD, M., DUARTE, P., OKPAKU, S., HUSTINX, R., & ALAVI, A. (1999). Adverse effects of edema on adjacent gray matter function in patients with brain tumor as determined by FDG-PET imaging. Journal of Nuclear Medicine, 40, 112.
Peer Reviewed verified by ORBi

HUSTINX, R., DOLIN, R., BENARD, F., BHATNAGAR, A., SMITH, R., JANG, S., & ALAVI, A. (1999). Impact of attenuation correction on the accuracy of FDG-PET in patients with abdominal tumors: An ROC analysis. Journal of Nuclear Medicine, 40, 139.
Peer Reviewed verified by ORBi

SMITH, R., HUSTINX, R., ADAM, L., & KARP, J. (1999). Clinical performance of the C-PET camera. Journal of Nuclear Medicine, 40, 280.
Peer Reviewed verified by ORBi

Hustinx, R., Smith, R. J., Benard, F., Bhatnagar, A., & Alavi, A. (1999). Can the standardized uptake value characterize primary brain tumors on FDG-PET? European Journal of Nuclear Medicine, 26 (11), 1501-9. doi:10.1007/s002590050487
Peer Reviewed verified by ORBi

Hustinx, R., & Alavi, A. (1999). SPECT and PET imaging of brain tumors. Neuroimaging Clinics of North America, 9 (4), 751-66.
Peer Reviewed verified by ORBi

Paulus, P., Sambon, A., Vivegnis, D., Hustinx, R., Moreau, P., Collignon, J., Deneufbourg, J.-M., & Rigo, P. (October 1998). 18fdg-Pet for the Assessment of Primary Head and Neck Tumors: Clinical, Computed Tomography, and Histopathological Correlation in 38 Patients. Laryngoscope, 108 (10), 1578-83. doi:10.1097/00005537-199810000-00029
Peer Reviewed verified by ORBi

Paquet, P., Hustinx, R., Rigo, P., & Pierard, G. (February 1998). Malignant Melanoma Staging Using Whole-Body Positron Emission Tomography. Melanoma Research, 8 (1), 59-62. doi:10.1097/00008390-199802000-00010
Peer Reviewed verified by ORBi

Palmedo, H., Biersack, H. J., Lastoria, S., Maublant, J., Prats, E., Stegner, H. E., Bourgeois, P., Hustinx, R., Hilson, A. J., & Bischof-Delaloye, A. (1998). Scintimammography with technetium-99m methoxyisobutylisonitrile: results of a prospective European multicentre trial. European Journal of Nuclear Medicine, 25 (4), 375-85. doi:10.1007/s002590050235
Peer Reviewed verified by ORBi

HUSTINX, R., HACKNEY, D., BENARD, F., ALAVI, J., ECK, S., JUDY, K., PHILIPS, P., & ALAVI, A. (1998). Evaluation of response to gene therapy for malignant gliomas with FDG PET imaging and MRI. Journal of Nuclear Medicine, 39, 255.
Peer Reviewed verified by ORBi

HUSTINX, R., BENARD, F., SHNIER, D., SMITH, R., & ALAVI, A. (1998). Can standardized uptake value (SUV) characterize brain tumors on FDG PET Scan ? Journal of Nuclear Medicine, 39, 164P-165.
Peer Reviewed verified by ORBi

Hustinx, R., Paulus, P., Jacquet, N., Jerusalem, G., Bury, T., & Rigo, P. (1998). Clinical evaluation of whole-body 18F-fluorodeoxyglucose positron emission tomography in the detection of liver metastases. Annals of Oncology, 9 (4), 397-401. doi:10.1023/A:1008290027419
Peer Reviewed verified by ORBi

BHATNAGAR, A., HUSTINX, R., SHNIER, D., KILROY, K., BENARD, F., & ALAVI, A. (1998). Stomach uptake in FDG PET scans: is it related to blood glucose level ? Journal of Nuclear Medicine, 39, 126P-127.
Peer Reviewed verified by ORBi

Bury, T., Dowlati, A., Paulus, P., Corhay, J.-L., Hustinx, R., Ghaye, B., Radermecker, M., & Rigo, P. (November 1997). Whole-body 18FDG positron emission tomography in the staging of non-small cell lung cancer. European Respiratory Journal, 10 (11), 2529-34. doi:10.1183/09031936.97.10112529
Peer Reviewed verified by ORBi

Rigo, P., Paulus, P., Bury, T., Jerusalem, G., Hustinx, R., Benoit, T., Larock, M.-P., & Willems, J. (1997). Clinical PET in Oncology. In H. Bergmann, A. Kroiss, ... Sinzinger H (Eds.), Radioactive Isotopes in Clinical Medicine and Research (pp. 3-14). Basel, Switzerland: Birhauser Verlag.

PAULUS, P., HENRY, S., HUSTINX, R., & RIGO, P. (1997). Improved head and neck FDG-PET imaging using segmented attenuation correction. European Journal of Nuclear Medicine, 24, 936.
Peer Reviewed verified by ORBi

PAULUS, P., SAMBON, A., HUSTINX, R., SERVILLE, M.-N., MOREAU, P., & RIGO, P. (1997). Use of positron emission tomography with 18 FDG in patients with head and neck cancers. Clinical usefulness to recurrence detection and staging of lymph node involvement. European Journal of Nuclear Medicine, 24, 996.
Peer Reviewed verified by ORBi

HUSTINX, R., PAULUS, P., JACQUET, N., & RIGO, P. (1997). Whole-body FDG-PET as a firstline procedure for detection and staging of recurrent rectal or digmoid carcinoma: preliminary results. European Journal of Nuclear Medicine, 24, 882.
Peer Reviewed verified by ORBi

Rigo, P., Paulus, P., Bury, T., Jerusalem, G., Hustinx, R., Benoit, T., Larock, M.-P., & Foidart, J. (1997). Clinical PET in oncology. Radioactive Isotopes in Clinical Medicine Research XXII.
Peer reviewed

PAULUS, P., VIVEGNIS, D., SAMBON, A., HUSTINX, R., MOREAU, P., & RIGO, P. (1997). Rôle de la TEP au 18FDG dans le bilan d'extension ganglionnaire et la détection des récidives des cancers de la tête et du cou. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 21, 347.
Peer Reviewed verified by ORBi

Paulus, P., Hustinx, R., Daenen, F., Comhair, N., & Rigo, P. (1997). Usefulness of 18fdg Positron Emission Tomography in Detection and Follow-up of Digestive Cancers. Acta Gastro-Enterologica Belgica, 60 (4, Oct-Dec), 278-80.
Peer Reviewed verified by ORBi

HUSTINX, R., PAULUS, P., BURY, T., CATALDO, D., RIGO, P., & FOIDART-WILLEMS, J. (1997). Efficacy of Tc-99m P829, a radiolabelled somatostatin analog in visualising mediastinal spread of non-small cell lung cancer. European Journal of Nuclear Medicine, 24, 959.
Peer Reviewed verified by ORBi

Rigo, P., Paulus, P., Kaschten, B., Hustinx, R., Bury, T., Jerusalem, G., Benoit, T., & Foidart-Willems, J. (December 1996). Oncological Applications of Positron Emission Tomography with Fluorine-18 Fluorodeoxyglucose. European Journal of Nuclear Medicine, 23 (12), 1641-74. doi:10.1007/BF01249629
Peer Reviewed verified by ORBi

DAENEN, F., HUSTINX, R., PAULUS, P., DEMEZ, P., JACQUET, N., & RIGO, P. (May 1996). Detection of recurrent colorectal carcinoma with whole-body FDG-PET. Journal of Nuclear Medicine, 37, 261.
Peer Reviewed verified by ORBi

HUSTINX, R., PAULUS, P., DAENEN, F., JERUSALEM, G., JACQUET, N., & RIGO, P. (May 1996). PET imaging of liver metastases: a retrospective study. Journal of Nuclear Medicine, 37, 250P-251.
Peer Reviewed verified by ORBi

Bury, T., Paulus, P., Weber, T., Hustinx, R., Corhay, J.-L., Rigo, P., & Radermecker, M. (April 1996). Comment j'explore ... une suspicion de cancer broncho-pulmonaire par tomographie a émission de positrons. Revue Médicale de Liège, 51 (4), 317-9.
Peer reviewed

Bury, T., Dowlati, A., Paulus, P., Hustinx, R., Radermecker, M., & Rigo, P. (February 1996). Staging of Non-Small-Cell Lung Cancer by Whole-Body Fluorine-18 Deoxyglucose Positron Emission Tomography. European Journal of Nuclear Medicine, 23 (2), 204-6. doi:10.1007/BF01731846
Peer Reviewed verified by ORBi

HUSTINX, R., PAULUS, P., BENOIT, T., JERUSALEM, G., JACQUET, N., & RIGO, P. (1996). Clinical value of whole body-body PET-FDG in the detection of liver metastases: preliminary results. European Journal of Nuclear Medicine, 23, 1110.
Peer Reviewed verified by ORBi

PAULUS, P., HUSTINX, R., BURY, T., RADERMECKER, M., & RIGO, P. (1996). FDG-PET and lung cancer: evaluation of solitary pulmonary nodule and mediastinal staging. Proceedings of the VIIth International PET Conference, Institute for Clinical PET.
Peer reviewed

PAULUS, P., BURY, T., HUSTINX, R., DOWLATI, A., & RIGO, P. (1996). Comparison of positron emission tomography and computed tomography in the mediastinal and extrathoracic staging of non-small cell lung cancer. Journal of Nuclear Medicine, 37, 260.
Peer Reviewed verified by ORBi

Hustinx, R., Paulus, D., Rigo, P., Yeung, H. W., Macapinlac, H. A., & Larson, S. M. (1996). Clinical PET in Oncology. France: GE Medical Systems.

Hustinx, R., Verloes, A., Grattagliano, B., Herens, C., Jamar, M., Soyeur, D., Schaaps, J.-P., & Koulischer, L. (01 September 1993). Monosomy 11q: Report of Two Familial Cases and Review of the Literature. American Journal of Medical Genetics, 47 (3), 312-7. doi:10.1002/ajmg.1320470303
Peer Reviewed verified by ORBi

Contact ORBi